<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Dietary interventions for induction and maintenance of remission in inflammatory bowel disease - Limketkai, BN - 2019 | Cochrane Library</title> <meta content="Dietary interventions for induction and maintenance of remission in inflammatory bowel disease - Limketkai, BN - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012839.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Dietary interventions for induction and maintenance of remission in inflammatory bowel disease - Limketkai, BN - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012839.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012839.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Dietary interventions for induction and maintenance of remission in inflammatory bowel disease" name="citation_title"/> <meta content="Berkeley N Limketkai" name="citation_author"/> <meta content="University of California Los Angeles" name="citation_author_institution"/> <meta content="berkeley.limketkai@gmail.com" name="citation_author_email"/> <meta content="Zipporah Iheozor‐Ejiofor" name="citation_author"/> <meta content="University of Central Lancashire" name="citation_author_institution"/> <meta content="Teuta Gjuladin‐Hellon" name="citation_author"/> <meta content="University of Central Lancashire" name="citation_author_institution"/> <meta content="Alyssa Parian" name="citation_author"/> <meta content="Johns Hopkins University" name="citation_author_institution"/> <meta content="Laura E Matarese" name="citation_author"/> <meta content="East Carolina University" name="citation_author_institution"/> <meta content="Kelly Bracewell" name="citation_author"/> <meta content="University of Central Lancashire" name="citation_author_institution"/> <meta content="John K MacDonald" name="citation_author"/> <meta content="Morris Gordon" name="citation_author"/> <meta content="University of Central Lancashire" name="citation_author_institution"/> <meta content="Gerard E Mullin" name="citation_author"/> <meta content="Johns Hopkins University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD012839.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/02/08" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012839.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012839.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012839.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Calcium, Dietary [therapeutic use]; Cattle; Colitis, Ulcerative [*diet therapy]; Crohn Disease [*diet therapy]; Dietary Carbohydrates [therapeutic use]; Dietary Fiber [therapeutic use]; Food, Organic; Meat; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012839.pub2&amp;doi=10.1002/14651858.CD012839.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WcPhDegp";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012839\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012839\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ru","ms","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012839.pub2",title:"Dietary interventions for induction and maintenance of remission in inflammatory bowel disease",firstPublishedDate:"Feb 8, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012839.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012839.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012839.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012839.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012839.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012839.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012839.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012839.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012839.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012839.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>17628 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012839.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-sec-0116"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-sec-0066"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-sec-0108"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/appendices#CD012839-sec-0121"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/table_n/CD012839StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/table_n/CD012839StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Dietary interventions for induction and maintenance of remission in inflammatory bowel disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Berkeley N Limketkai</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0003">Zipporah Iheozor‐Ejiofor</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0004">Teuta Gjuladin‐Hellon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0005">Alyssa Parian</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0006">Laura E Matarese</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0007">Kelly Bracewell</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0008">John K MacDonald</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0009">Morris Gordon</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information#CD012839-cr-0010">Gerard E Mullin</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information/en#CD012839-sec-0124">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 08 February 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012839.pub2">https://doi.org/10.1002/14651858.CD012839.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012839-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012839-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012839-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012839-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012839-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012839-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012839-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012839-abs-0001" lang="en"> <section id="CD012839-sec-0001"> <h3 class="title" id="CD012839-sec-0001">Background</h3> <p>Inflammatory bowel disease (IBD), comprised of Crohn's disease (CD) and ulcerative colitis (UC), is characterized by chronic mucosal inflammation, frequent hospitalizations, adverse health economics, and compromised quality of life. Diet has been hypothesised to influence IBD activity. </p> </section> <section id="CD012839-sec-0002"> <h3 class="title" id="CD012839-sec-0002">Objectives</h3> <p>To evaluate the efficacy and safety of dietary interventions on IBD outcomes.</p> </section> <section id="CD012839-sec-0003"> <h3 class="title" id="CD012839-sec-0003">Search methods</h3> <p>We searched the Cochrane IBD Group Specialized Register, CENTRAL, MEDLINE, Embase, Web of Science, Clinicaltrials.gov and the WHO ICTRP from inception to 31 January 2019. We also scanned reference lists of included studies, relevant reviews and guidelines. </p> </section> <section id="CD012839-sec-0004"> <h3 class="title" id="CD012839-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) that compared the effects of dietary manipulations to other diets in participants with IBD. Studies that exclusively focused on enteral nutrition, oral nutrient supplementation, medical foods, probiotics, and parenteral nutrition were excluded. </p> </section> <section id="CD012839-sec-0005"> <h3 class="title" id="CD012839-sec-0005">Data collection and analysis</h3> <p>Two review authors independently performed study selection, extracted data and assessed bias using the risk of bias tool. We conducted meta‐analyses where possible using a random‐effects model and calculated the risk ratio (RR) and corresponding 95% confidence interval (CI) for dichotomous outcomes. We assessed the certainty of evidence using GRADE. </p> </section> <section id="CD012839-sec-0006"> <h3 class="title" id="CD012839-sec-0006">Main results</h3> <p>The review included 18 RCTs with 1878 participants. The studies assessed different dietary interventions for active CD (six studies), inactive CD (seven studies), active UC (one study) and inactive UC (four studies). Dietary interventions involved either the consumption of low amounts or complete exclusion of one or more food groups known to trigger IBD symptoms. There was limited scope for data pooling as the interventions and control diets were diverse. The studies were mostly inadequately powered. Fourteen studies were rated as high risk of bias. The other studies were rated as unclear risk of bias. </p> <p>The effect of high fiber, low refined carbohydrates, low microparticle diet, low calcium diet, symptoms‐guided diet and highly restricted organic diet on clinical remission in active CD is uncertain. At 4 weeks, remission was induced in: 100% (4/4) of participants in the low refined carbohydrates diet group compared to 0% (0/3) of participants in the control group (RR 7.20, 95% CI 0.53 to 97.83; 7 participants; 1 study; very low certainty evidence). At 16 weeks, 44% (23/52) of participants in the low microparticle diet achieved clinical remission compared to 25% (13/51) of control‐group participants (RR 3.13, 95% CI 0.22 to 43.84; 103 participants; 2 studies; I² = 73%; very low certainty evidence). Fifty per cent (16/32) of participants in the symptoms‐guided diet group achieved clinical remission compared to 0% (0/19) of control group participants (RR 20.00, 95% CI 1.27 to 315.40; 51 participants ; 1 study; very low certainty evidence) (follow‐up unclear). At 24 weeks, 50% (4/8) of participants in the highly restricted organic diet achieved clinical remission compared to 50% (5/10) of participants in the control group (RR 1.00, 95% CI 0.39 to 2.53; 18 participants; 1 study; very low certainty evidence). At 16 weeks, 37% (16/43) participants following a low calcium diet achieved clinical remission compared to 30% (12/40) in the control group (RR 1.24, 95% CI 0.67 to 2.29; 83 participants; 1 study; very low certainty evidence). </p> <p>The effect of low refined carbohydrate diets, symptoms‐guided diets and low red processed meat diets on relapse in inactive CD is uncertain. At 12 to 24 months, 67% (176/264) of participants in low refined carbohydrate diet relapsed compared to 64% (193/303) in the control group (RR 1.04, 95% CI 0.87 to 1.25; 567 participants; 3 studies; I² = 35%; low certainty evidence). At 6 to 24 months, 48% (24/50) of participants in the symptoms‐guided diet group relapsed compared to 83% (40/48) participants in the control diet (RR 0.53, 95% CI 0.28 to 1.01; 98 participants ; 2 studies; I² = 54%; low certainty evidence). At 48 weeks, 66% (63/96) of participants in the low red and processed meat diet group relapsed compared to 63% (75/118) of the control group (RR 1.03, 95% CI 0.85 to 1.26; 214 participants; 1 study; low certainty evidence). At 12 months, 0% (0/16) of participants on an exclusion diet comprised of low disaccharides / grains / saturated fats / red and processed meat experienced clinical relapse compared to 26% (10/38) of participants on a control group (RR 0.11, 95% CI 0.01 to 1.76; 54 participants; 1 study; very low certainty evidence). </p> <p>The effect of a symptoms‐guided diet on clinical remission in active UC is uncertain. At six weeks, 36% (4/11) of symptoms‐guided diet participants achieved remission compared to 0% (0/10) of usual diet participants (RR 8.25, 95% CI 0.50 to 136.33; 21 participants; 1 study; very low certainty evidence). </p> <p>The effect of the Alberta‐based anti‐inflammatory diet, the Carrageenan‐free diet or milk‐free diet on relapse rates in inactive UC is uncertain. At 6 months, 36% (5/14) of participants in the Alberta‐based anti‐inflammatory diet group relapsed compared to 29% (4/14) of participants in the control group (RR 1.25, 95% CI 0.42 to 3.70; 28 participants; 1 study; very low certainty evidence). Thirty per cent (3/10) of participants following the carrageenan‐free diet for 12 months relapsed compared to 60% (3/5) of the participants in the control group (RR 0.50, 95% CI 0.15 to 1.64; 15 participants; 1 study; very low certainty evidence). At 12 months, 59% (23/39) of milk free diet participants relapsed compared to 68% (26/38) of control diet participants (RR 0.83, 95% CI 0.60 to 1.15; 77 participants; 2 studies; I² = 0%; low certainty evidence). </p> <p>None of the included studies reported on diet‐related adverse events.</p> </section> <section id="CD012839-sec-0007"> <h3 class="title" id="CD012839-sec-0007">Authors' conclusions</h3> <p>The effects of dietary interventions on CD and UC are uncertain. Thus no firm conclusions regarding the benefits and harms of dietary interventions in CD and UC can be drawn. There is need for consensus on the composition of dietary interventions in IBD and more RCTs are required to evaluate these interventions. Currently, there are at least five ongoing studies (estimated enrollment of 498 participants). This review will be updated when the results of these studies are available. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012839-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012839-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012839-abs-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012839-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012839-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012839-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012839-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012839-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012839-abs-0007">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012839-abs-0006" lang="en"> <h3>Diets for inducing and maintaining remission in inflammatory bowel disease (IBD)</h3> <p><b>What is the aim of the review?</b> </p> <p>The aim was to find out what diets can be used to induce or maintain remission in people with IBD. </p> <p><b>What is IBD?</b> </p> <p>IBD involves inflammation of the gastrointestinal tract. Ulcerative colitis (UC) and Crohn’s disease (CD) are the most common types of IBD. Symptoms include abdominal pain, diarrhea and rectal bleeding. IBD is characterized by periods of relapse where people experience symptoms of active disease and periods of remission when the symptoms stop. While some foods may provoke IBD symptoms, little is known about whether diets help to induce or maintain remission in IBD. </p> <p><b>How up to date is the review?</b> </p> <p>We searched for studies up to 31 January 2019.</p> <p><b>What are the main results of the review?</b> </p> <p>We found 18 studies including 1878 participants. The diets studied included reduction or exclusion of foods believed to provoke IBD symptoms. These diets were compared with 'usual' diets. The studies assessed dietary interventions for active CD (six studies), inactive CD (seven studies), active UC (one study) and inactive UC (four studies). One study recruited children, while the rest included adults. The studies were poorly designed and had few participants. As a result the overall quality of the evidence was very low. </p> <p>The effect of high fiber, low refined carbohydrates, low microparticle, low calcium, symptoms‐guided diet and highly restricted organic diet on clinical remission in active CD is uncertain. In one study, remission was achieved at 4 weeks in 100% (4/4) of low refined carbohydrates participants compared to 0% (0/3) of usual diet participants. In a pooled analysis of two studies, 44% (23/52) of low microparticle participants achieved remission at 16 weeks compared to 25% (13/51) of usual diet participants. One study found that 50% (16/32) of symptoms‐guided participants achieved remission compared to 0% (0/19) of usual diet participants. One study found that 50% (4/8) of highly‐restricted organic diet participants achieved remission at 24 weeks compared to 50% (5/10) of usual diet participants. One study found that 37% (16/43) of low‐calcium participants achieved remission at 16 weeks compared to 30% (12/40) of usual diet participants. </p> <p>The effect of low refined carbohydrate, symptoms‐guided and low red processed meat diets on relapse in inactive CD is uncertain. In a pooled analysis of three studies, 67% (176/264) of low refined carbohydrate participants relapsed at 12 to 24 months compared to 64% (193/303) of usual diet participants. In a pooled analysis of two studies, 48% (24/50) of symptoms‐guided participants relapsed at 6 to 24 months compared to 83% (40/48) of usual diet participants. One study found that 66% (63/96) of low red and processed meat participants relapsed at 48 weeks compared to 63% (75/118) of usual diet participants. One study showed that 0% (0/16) of exclusion diet participants (i.e. low disaccharides, grains, saturated fats, red and processed meat) relapsed at 12 months compared to 26% (10/38) of usual diet participants. </p> <p>The effect of a symptoms‐guided diet on clinical remission in active UC is uncertain. In one study, 36% (4/11) of symptoms‐guided participants achieved remission at six weeks compared to 0% (0/10) in the usual diet group. </p> <p>The effect of the Alberta‐based anti‐inflammatory diet, the Carrageenan‐free diet and the milk‐free diet on relapse in inactive UC is uncertain. In one study, 36% (5/14) of Alberta‐based diet participants relapsed at 6 months compared to 29% (4/14) of usual diet participants. In one study, 30% (3/10) of carrageenan‐free participants relapsed at 12 months compared to 60% (3/5) of usual diet participants. At 12 months, 59% (23/39) of milk‐free diet participants relapsed compared to 68% (26/38) in the usual diet group. </p> <p>None of the included studies reported on diet‐related side effects.</p> <p><b>Conclusions</b> </p> <p>The effects of dietary interventions on CD and UC are uncertain. Thus no firm conclusions regarding the benefits and harms of dietary interventions in CD and UC can be drawn. There is need for consensus on the composition of dietary interventions in IBD and more studies are required to evaluate these interventions. Currently, there are five ongoing studies (estimated enrollment of 498 participants). This review will be updated when the results of these studies are available. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012839-sec-0116" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012839-sec-0116">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012839-sec-0171">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012839-sec-0116"></div> <h3 class="title" id="CD012839-sec-0117">Implications for practice</h3> <section id="CD012839-sec-0117"> <p>The effects of dietary interventions on CD and UC are uncertain. Thus no firm conclusions regarding the benefits and harms of dietary interventions in CD and UC can be drawn. This evidence was of very low certainty due to sparse data from heterogenous studies which had limited scope for pooling. Adverse effects of the interventions were not reported. </p> </section> <h3 class="title" id="CD012839-sec-0118">Implications for research</h3> <section id="CD012839-sec-0118"> <p>There is need for consensus on the composition of dietary interventions in IBD and more RCTs are required to evaluate these interventions. Around 15% of the excluded studies which otherwise would have met the inclusion criteria had mixed populations of participants with UC and CD and did not report separate results for each group. As a result, these studies did not contribute to the sum of synthesised evidence. Future studies must treat these populations separately to allow meaningful interpretations to take place. </p> <p>We need researchers to agree to a standardized, dietetically informed, framework or protocol for such diets being explored in RCTs to allow the wider research community to collaboratively and iteratively build on each others' research. Future RCTs need to report sufficient details on randomization, allocation concealment, blinding of outcome assessors and outcomes including adverse events. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012839-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012839-sec-0036"></div> <div class="table" id="CD012839-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intervention diet compared to control diet for induction of remission in active Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intervention diet compared to control diet in active Crohn's disease for induction of remission in active Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with active Crohn's disease<br/> <b>Setting:</b> home<br/> <b>Intervention:</b> intervention diet (various)<br/> <b>Comparison:</b> control diet (various) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control diet</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intervention diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission at 4 weeks ‐ High‐fiber, low refined carbohydrates diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 7.20<br/> (0.53 to 97.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We were unable to calculate absolute effects. Remission was induced in 100% (4/4) of participants in the low refined carbohydrates diet group compared to 0% (0/3) in the control group </p> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission at 16 weeks ‐ Low microparticle diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.13<br/> (0.22 to 43.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>103 (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>798 per 1,000<br/> (56 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission at 16 weeks ‐ Low calcium diet</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.24</p> <p>(0.67 to 2.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>83 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>372 per 1000 (201 to 687)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission (timeframe not reported) ‐ Symptoms‐guided diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 20.00<br/> (1.27 to 315.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>51 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We were unable to calculate absolute effects. Remission was induced in 50% (16/32) of participants in the symptoms‐guided diet group compared to 0% (0/19) in the control </p> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission at 6 weeks ‐ Highly restricted, organic diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.39 to 2.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>18 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1,000<br/> (195 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life (timeframe not reported) ‐ IBDQ ‐ Symptoms‐guided diet</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean health related quality of life ‐ IBDQ ‐ was 0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 23.75 higher</p> <p>(7.12 higher to 40.38 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health‐related quality of life at 6 weeks ‐ IBDQ ‐ Highly restricted, organic diet</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean health related quality of life ‐ IBDQ was 0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 4 higher</p> <p>(17.86 lower to 25.86 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>None reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR</b> : risk ratio; <b>CDAI:</b> Crohn's disease activity index; <b>IBDQ:</b> Inflammatory Bowel Disease Questionnaire; <b>MD:</b> Mean difference. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high or unclear risk of bias </p> <p><sup>2</sup> Downgraded two levels due to serious imprecision (4 events) </p> <p><sup>3</sup> Downgraded two levels due to serious imprecision (36 events) </p> <p><sup>4</sup> Downgraded two levels due to serious imprecision (28 events) </p> <p><sup>5</sup> Downgraded two levels due to serious imprecision (16 events) </p> <p><sup>6</sup> Downgraded two levels due to serious imprecision (9 events) </p> <p><sup>7</sup> Downgraded one level due to imprecision (51 participants) </p> <p><sup>8</sup> Downgraded two levels due to serious imprecision (14 participants) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012839-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intervention diet compared to control diet for maintenance of remission in inactive Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intervention diet compared to control diet for maintenance of remission in inactive Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with inactive Crohn's disease<br/> <b>Setting:</b> home<br/> <b>Intervention:</b> intervention diet (various)<br/> <b>Comparison:</b> control diet (various) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control diet</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intervention diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 12 to 24 months ‐ Low refined carbohydrate diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.04<br/> (0.87 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>567 (3 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined as CDAI &gt; 150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>637 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>662 per 1,000<br/> (554 to 796) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 6 to 24 months ‐ Symptoms‐guided diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.53<br/> (0.28 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>98 (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined as CDAI &gt; 150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>833 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>442 per 1,000<br/> (233 to 842) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 48 weeks ‐ Low red, processed meat diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.85 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>214 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined as CDAI &gt; 150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>636 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>655 per 1,000<br/> (540 to 801) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 12 months ‐ Exclusion diets (low disaccharides, grains, saturated fats, red and processed meats) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.11<br/> (0.01 to 1.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>54 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1,000<br/> (3 to 463) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>None reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CDAI:</b> Crohn's disease activity index. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high or unclear risk of bias </p> <p><sup>2</sup> Downgraded one level due to imprecision (369 events) </p> <p><sup>3</sup> Downgraded one level due to imprecision (64 events) </p> <p><sup>4</sup> Downgraded one level due to imprecision (138 events) </p> <p><sup>5</sup> Downgraded two levels due to serious imprecision (10 events) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012839-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Intervention diet compared to control diet for induction of remission in active ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intervention diet compared to control diet for the induction of remission in active ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population: p</b> eople with active ulcerative colitis<br/> <b>Setting:</b> home<br/> <b>Intervention:</b> intervention diet (various)<br/> <b>Comparison:</b> control diet (various) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control diet</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intervention diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission ‐ Symptoms‐guided diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 8.25<br/> (0.50 to 136.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>21 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We were unable to calculate absolute effects. Remission was induced in 36% (4/11) of symptoms‐guided diet participants compared to 0% (0/10) of the control group </p> <p>Remission was defined as passage of normal stools with absence of rectal bleeding</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health‐related quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high or unclear risk of bias </p> <p><sup>2</sup> Downgraded two levels due to serious imprecision (4 events) </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012839-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Intervention diet compared to control diet for maintenance of remission in inactive ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intervention diet compared to control diet for maintenance of remission in inactive ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Participants with inactive ulcerative colitis<br/> <b>Setting:</b> home<br/> <b>Intervention:</b> Intervention diet (various)<br/> <b>Comparison:</b> control diet (various) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control diet in inactive ulcerative colitis</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Intervention diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 6 months ‐ Anti‐inflammatory diet (Alberta‐based)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/> (0.42 to 3.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined by a Mayo score &gt; 3</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>357 per 1,000<br/> (120 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 12 months ‐ Carrageenan‐free diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/> (0.15 to 1.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>15<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined by an increase in the Simple Clinical Colitis Activity Index of &gt; 2 points </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>600 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1,000<br/> (90 to 984) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 12 months ‐ Milk free diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.83<br/> (0.60 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined by a Pediatric Ulcerative Colitis Activity Index score &gt; 10 points or by clinical symptoms (4 or more diarrhea movements per day with visible blood) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>684 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>568 per 1,000<br/> (411 to 787) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health related quality of life at 12 months ‐ SIBDQ ‐ Carrageenan‐free diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean health related quality of life ‐ SIBDQ was 0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.7 higher<br/> (4.83 lower to 8.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>SIBDQ:</b> Short Inflammatory Bowel Disease Questionnaire; <b>MD:</b> Mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high or unclear risk of bias </p> <p><sup>2</sup> Downgraded two levels due to serious imprecision (9 events) </p> <p><sup>3</sup> Downgraded two levels due to serious imprecision (6 events) </p> <p><sup>4</sup> Downgraded one level due to imprecision (49 events) </p> <p><sup>5</sup> Downgraded two levels due to very serious imprecision (12 participants) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012839-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012839-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012839-sec-0134">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD012839-sec-0037"></div> <section id="CD012839-sec-0038"> <h3 class="title" id="CD012839-sec-0038">Description of the condition</h3> <p>Inflammatory bowel disease (IBD), predominantly comprised of Crohn's disease (CD) and ulcerative colitis (UC), is characterized by chronic mucosal inflammation, frequent hospitalizations, adverse health economics, and compromised quality of life. Common symptoms of IBD include abdominal pain, diarrhoea, and rectal bleeding. Inflammation in UC is limited to the colonic mucosa. Inflammation in CD is a non‐uniform transmural disease process that can occur anywhere along the alimentary tract and can lead to complications including intestinal strictures, fistulization to surrounding tissues or organs, and abscesses. Other complications that can arise in both CD and UC include intestinal cancer, nutrient malabsorption, malnutrition, and extra‐intestinal manifestations (e.g. arthralgias, dermatologic lesions, uveitis). </p> <p>The incidence of CD is approximately 20 per 100,000 person‐years in North America and 13 per 100,000 person‐years in Europe (<a href="./references#CD012839-bbs2-0101" title="MolodeckyNA , SoonIS , RabiDM , GhaliWA , FerrisM , ChernoffG , et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology2012;142:46‐54. ">Molodecky 2012</a>). Higher disease incidence and prevalence are seen in North America and Europe compared to lower rates in Asia and the Middle East. Nonetheless, the incidence and prevalence of IBD have more recently been rising in Asia and the Middle East, and individuals from these geographic regions experience an increased risk of developing IBD when immigrating to North America or Europe (<a href="./references#CD012839-bbs2-0067" title="BenchimolEI , MackDR , GuttmannA , NguyenGC , ToT , MojaverianN , et al. Inflammatory bowel disease in immigrants to Canada and their children: a population‐based cohort study. American Journal of Gastroenterology2015;110:553‐63. ">Benchimol 2015</a>; <a href="./references#CD012839-bbs2-0108" title="PinskV , LembergD A , GrewalK , BarkerC C , SchreiberR A , JacobsonK . Inflammatory bowel disease in the South Asian pediatric population of British Columbia. American Journal of Gastroenterology2007;102:1077‐83. ">Pinsk 2007</a>). This overall increase in IBD among populations not traditionally associated with IBD has been hypothesized to stem from the Westernization of lifestyles and diets (<a href="./references#CD012839-bbs2-0078" title="FosterA , JacobsonK . Changing incidence of inflammatory bowel disease: environmental influences and lessons learnt from the South Asian population. Frontiers in Pediatrics2013;1:34. ">Foster 2013</a>; <a href="./references#CD012839-bbs2-0105" title="OoiCJ , MakhariaGK , HilmiI , GibsonPR , FockKM , AhujaV , et al. Asia Pacific consensus statements on Crohn's disease. Part 1: definition, diagnosis, and epidemiology. Journal of Gastroenterology and Hepatology2016;31:45‐55. ">Ooi 2016</a>). For example, immigrants from Latin American to South Florida develop IBD at a later age; however, first‐generation US‐born Hispanics develop IBD at an age similar to non‐Hispanic whites (<a href="./references#CD012839-bbs2-0075" title="DamasOM , JahannDA , ReznikR , McCauleyJL , TamarizL , DeshpandeAR , et al. Phenotypic manifestations of Inflammatory Bowel Disease differ between Hispanics and non‐Hispanic whites: results of a large cohort study. American Journal of Gastroenterology2013;108(2):231‐9. ">Damas 2013</a>). The development of IBD in this generation of immigrants is also occurring sooner than previously documented (<a href="./references#CD012839-bbs2-0076" title="DamasOM , AvalosDJ , PalacioAM , GomezL , QuinteroMA , DeshpandeAR , et al. Inflammatory bowel disease is presenting sooner after immigration in more recent US immigrants from Cuba. Alimentary Pharmacology and Therapeutics2017;46(3):303‐9. ">Damas 2017</a>). </p> <p>Factors that contribute to the development of IBD are unclear, although the current paradigm of pathogenesis involves the interaction of disease‐susceptibility genes, inappropriate immune response, gut microbiota, and environmental factors (<a href="./references#CD012839-bbs2-0061" title="AbrahamC , ChoJH . Inflammatory bowel disease. New England Journal of Medicine2009;361:2066‐78. ">Abraham 2009</a>). Some potential environmental factors include gastrointestinal infections, antibiotics, tobacco use, and oral contraceptives (<a href="./references#CD012839-bbs2-0069" title="BirrenbachT , BöckerU . Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications. Inflammatory Bowel Diseases2004;10:848‐59. ">Birrenbach 2004</a>; <a href="./references#CD012839-bbs2-0073" title="CornishJA , TanE , SimillisC , ClarkSK , TeareJ , TekkisPP . The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta‐analysis. American Journal of Gastroenterology2008;103:2394‐400. ">Cornish 2008</a>; <a href="./references#CD012839-bbs2-0080" title="García RodríguezLA , RuigómezA , PanésJ . Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology2006;130:1588‐94. ">Garcia Rodriguez 2006</a>; <a href="./references#CD012839-bbs2-0083" title="GradelKO , NielsenHL , SchønheyderHC , EjlertsenT , KristensenB , NielsenH . Increased short‐ and long‐term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology2009;137:495‐501. ">Gradel 2009</a>; <a href="./references#CD012839-bbs2-0116" title="UngaroR , BernsteinCN , GearryR , HviidA , KolhoKL , KronmanMP , et al. Antibiotics associated with increased risk of new‐onset Crohn's disease but not ulcerative colitis: a meta‐analysis. American Journal of Gastroenterology2014;109:1728‐38. ">Ungaro 2014</a>). Epidemiologic studies have implicated diet in IBD pathogenesis (<a href="./references#CD012839-bbs2-0072" title="Chapman‐KiddellCA , DaviesPS , GillenL , Radford‐SmithGL . Role of diet in the development of inflammatory bowel disease. Inflammatory Bowel Diseases2010;16:137‐51. ">Chapman‐Kiddell 2010</a>). Increased intake of refined sugars has been associated with an increased risk of CD in several small cohort studies (<a href="./references#CD012839-bbs2-0068" title="Bianchi PorroG , PanzaE . Smoking, sugar, and inflammatory bowel disease. British Medical Journal (Clinical Research Edition)1985;291:971‐2. ">Bianchi 1985</a>; <a href="./references#CD012839-bbs2-0088" title="HansenTS , JessT , VindI , ElkjaerM , NielsenMF , GamborgM , et al. Environmental factors in inflammatory bowel disease: a case‐control study based on a Danish inception cohort. Journal of Crohn's and Colitis2011;5:577‐84. ">Hansen 2011</a>; <a href="./references#CD012839-bbs2-0091" title="JakobsenC , PaerregaardA , MunkholmP , WewerV . Environmental factors and risk of developing paediatric inflammatory bowel disease ‐‐ a population based study 2007‐2009. Journal of Crohn's and Colitis2013;7:79‐88. ">Jakobsen 2013</a>; <a href="./references#CD012839-bbs2-0099" title="MartiniGA , BrandesJW . Increased consumption of refined carbohydrates in patients with Crohn's disease. Klinische Wochenschrift1976;54:367‐71. ">Martini 1976</a>; <a href="./references#CD012839-bbs2-0114" title="SilkoffK , HallakA , YegenaL , RozenP , MayberryJF , RhodesJ , et al. Consumption of refined carbohydrate by patients with Crohn's disease in Tel‐Aviv‐Yafo. Postgraduate Medical Journal1980;56:842‐6. ">Silkoff 1980</a>). Other studies have associated dietary fiber consumption with a reduced risk of CD (<a href="./references#CD012839-bbs2-0063" title="AmreDK , D'SouzaS , MorganK , SeidmanG , LambretteP , GrimardG , et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn's disease in children. American Journal of Gastroenterology2007;102:2016‐25. ">Amre 2007</a>; <a href="./references#CD012839-bbs2-0107" title="PerssonPG , AhlbomA , HellersG . Diet and inflammatory bowel disease: a case‐control study. Epidemiology1992;3:47‐52. ">Persson 1992</a>; <a href="./references#CD012839-bbs2-0115" title="ThorntonJR , EmmettPM , HeatonKW . Diet and Crohn's disease: characteristics of the pre‐illness diet. British Medical Journal1979;2:762‐4. ">Thornton 1979</a>). An analysis of the Nurses' Health Study that included 170,776 adult women, who were prospectively followed over 26 years, revealed that long‐term consumption of dietary fiber was associated with a reduced incidence of CD (<a href="./references#CD012839-bbs2-0064" title="AnanthakrishnanAN , KhaliliH , KonijetiGG , HiguchiLM , deSilvaP , KorzenikJR , et al. A prospective study of long‐term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology2013;145:970‐7. ">Ananthakrishnan 2013</a>). Compared with the lowest quintile of energy‐adjusted cumulative average intake of dietary fiber, intake of the highest quintile (median of 24.3 g/day of dietary fiber) was associated with a 40% reduction in risk of CD. Fiber derived from fruits was significantly associated with a reduced risk of CD, while fiber from vegetables, cereals, and whole grains was not associated with a reduced risk of IBD. A separate analysis of the Nurses’ Health Study revealed that higher intakes of fruits, vegetables, and fish in high school were associated with a 53% lower risk of developing CD with fish having the greatest impact (<a href="./references#CD012839-bbs2-0066" title="AnanthakrishnanAN , KhaliliH , SongM , HiguchiLM , RichterJM , NimptschK , et al. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflammatory Bowel Diseases2015;21:2311‐9. ">Ananthakrishnan 2015</a>). Dietary fat may also play a role in CD pathogenesis, although this relationship appears less clear. Some studies have associated an increased fat intake with CD risk (<a href="./references#CD012839-bbs2-0090" title="HouJK , AbrahamB , El‐SeragH . Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. American Journal of Gastroenterology2011;106:563‐73. ">Hou 2011</a>; <a href="./references#CD012839-bbs2-0111" title="ReifS , KleinI , LubinF , FarbsteinM , HallakA , GilatT . Pre‐illness dietary factors in inflammatory bowel disease. Gut1997;40:754‐60. ">Reif 1997</a>; <a href="./references#CD012839-bbs2-0112" title="SakamotoN , KonoS , WakaiK , FukudaY , SatomiM , ShimoyamaT , et al. Dietary risk factors for inflammatory bowel disease: a multicenter case‐control study in Japan. Inflammatory Bowel Diseases2005;11:154‐63. ">Sakamoto 2005</a>). However, an analysis of the large prospective Nurses' Health Study did not find an association between the intake of total fat, saturated fats, unsaturated fats, omega‐6 polyunsaturated fatty acids (PUFAs), or omega‐3 PUFAs and CD risk (<a href="./references#CD012839-bbs2-0065" title="AnanthakrishnanAN , KhaliliH , KonijetiGG , HiguchiLM , deSilvaP , FuchsCS , et al. Long‐term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut2014;63:776‐84. ">Ananthakrishnan 2014</a>). A greater intake of omega‐3 PUFAs and higher ratio of n‐3:n‐6 PUFAs were associated with a lower risk of UC. Furthermore, high long‐term intake of trans‐unsaturated fatty acids was associated with a trend towards an increased incidence of UC. <a href="#CD012839-tbl-0005">Table 1</a> summarizes the influence of some dietary components on the risk of IBD. </p> <div class="table" id="CD012839-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Dietary components can influence risk of inflammatory bowel disease</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dietary Component</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect on IBD Risk</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>References</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Animal Protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0093" title="JantchouP , MoroisS , Clavel‐ChapelonF , Boutron‐RuaultMC , CarbonnelF . Animal protein intake and risk of Inflammatory Bowel Disease: the E3N prospective study. American Journal of Gastroenterology2010;105(10):2195‐201. ">Jantchou 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heme iron, sulfur</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0066" title="AnanthakrishnanAN , KhaliliH , SongM , HiguchiLM , RichterJM , NimptschK , et al. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflammatory Bowel Diseases2015;21:2311‐9. ">Ananthakrishnan 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Refined sugars</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0092" title="JarnerotG , JarnmarkI , NilssonK . Consumption of refined sugar by patients with Crohn’s disease, ulcerative colitis, or irritable bowel syndrome. Scandinavian Journal of Gastroenterology1983;18(8):999‐1002. ">Janerot 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High trans‐fat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0065" title="AnanthakrishnanAN , KhaliliH , KonijetiGG , HiguchiLM , deSilvaP , FuchsCS , et al. Long‐term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut2014;63:776‐84. ">Ananthakrishnan 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fiber</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0066" title="AnanthakrishnanAN , KhaliliH , SongM , HiguchiLM , RichterJM , NimptschK , et al. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflammatory Bowel Diseases2015;21:2311‐9. ">Ananthakrishnan 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fruit</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0090" title="HouJK , AbrahamB , El‐SeragH . Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. American Journal of Gastroenterology2011;106:563‐73. ">Hou 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vegetables</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0090" title="HouJK , AbrahamB , El‐SeragH . Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. American Journal of Gastroenterology2011;106:563‐73. ">Hou 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High omega‐3 fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0071" title="ChanSS , LubenR , OlsenA , TjonnelandA , KaaksR , LindgrenS , et al. Association between high dietary intake of the n‐3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease. Alimentary Pharmacology and Therapeutics2014;39(8):834‐42. ">Chan 2014</a> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Adpated from <a href="./references#CD012839-bbs2-0102" title="MullinGE . Role of diet in Inflammatory Bowel Disease. Presented at: Digestive Disease Week; May 2016; San Diego, CA. ">Mullin 2016</a>. </p> </div> </div> <p>Given its potential effects on disease pathogenesis, dietary intake has similarly been hypothesized to influence disease activity. For instance, exclusive enteral nutrition may be effective for the induction and maintenance of remission in pediatric CD (<a href="./references#CD012839-bbs2-0062" title="AkobengAK , ZhangD , GordonM , MacDonaldJK . Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews2018, Issue 8. [DOI: 10.1002/14651858.CD005984.pub3] ">Akobeng 2018</a>; <a href="./references#CD012839-bbs2-0074" title="CritchJ , DayAS , OtleyA , King‐MooreC , TeitelbaumJE , ShashidharH , et al. Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition2012;54:298‐305. ">Critch 2012</a>; <a href="./references#CD012839-bbs2-0103" title="NarulaN , DhillonA , ZhangD , SherlockME , TondeurM , ZachosM . Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews2018, Issue 4. [DOI: 10.1002/14651858.CD000542.pub3] ">Narula 2018</a>). A high intake of red and processed meat or alcoholic beverages may increase the risk of a UC flare among adults (<a href="./references#CD012839-bbs2-0094" title="JowettSL , SealCJ , PearceMS , PhillipsE , GregoryW , BartonJR , et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut2004;53(10):1479‐84.. ">Jowett 2004</a>). Diet‐derived micronutrients, such as zinc, iron, and vitamin D, may have modifying effects on immunity, barrier function, and oxidative load with a downstream potential to impact the course of CD (<a href="./references#CD012839-bbs2-0070" title="BrownAC , RampertabSD , MullinGE . Existing dietary guidelines for Crohn's disease and ulcerative colitis. Expert Review of Gastroenterology and Hepatology2011;5:411‐25. ">Brown 2011</a>; <a href="./references#CD012839-bbs2-0096" title="Lih‐BrodyL , PowellSR , CollierKP , ReddyGM , CerchiaR , KahnE , et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Digestive Diseases and Sciences1996;41:2078‐86. ">Lih‐Brody 1996</a>; <a href="./references#CD012839-bbs2-0098" title="LimketkaiBN , BechtoldML , NguyenDL . Vitamin D and the pathogenesis of Inflammatory Bowel Disease. Current Gastroenterology Reports2016;18:52. ">Limketkai 2016</a>). There may be a role of nutritional therapies for the induction and maintenance of remission in IBD, although the potential efficacy may vary according to diet composition, disease type, and age group (pediatric or adult). </p> </section> <section id="CD012839-sec-0039"> <h3 class="title" id="CD012839-sec-0039">Description of the intervention</h3> <p>The intervention is a controlled manipulation of the subject’s oral diet by a deliberate change in the consumption of food (i.e. no formulas or supplements used) for a specified period of time. </p> </section> <section id="CD012839-sec-0040"> <h3 class="title" id="CD012839-sec-0040">How the intervention might work</h3> <p>The mechanisms that drive the benefits or harms of diets in IBD are unclear, although studies on dietary macronutrients may provide some insight. For instance, omega‐6 PUFAs are pro‐inflammatory mediators, while omega‐3 PUFAs, medium‐chain oils, and a family of diverse plant‐derived flavonoids (e.g. phytonutrients) have anti‐inflammatory properties (<a href="./references#CD012839-bbs2-0095" title="KonoH , FujiiH , OgikuM , TsuchiyaM , IshiiK , HaraM . Enteral diets enriched with medium‐chain triglycerides and N‐3 fatty acids prevent chemically induced experimental colitis in rats. Translational Research2010;156:282‐91. ">Kono 2010</a>; <a href="./references#CD012839-bbs2-0106" title="PapadaE , KalioraAC , GioxariA , PapaloisA , ForbesA . Anti‐inflammatory effect of elemental diets with different fat composition in experimental colitis. British Journal of Nutrition2014;111:1213‐20. ">Papada 2014</a>). Dietary fiber can be converted by intestinal bacteria to short‐chain fatty acids, which have anti‐inflammatory properties (<a href="./references#CD012839-bbs2-0079" title="GalvezJ , Rodríguez‐CabezasME , ZarzueloA . Effects of dietary fiber on inflammatory bowel disease. Molecular Nutrition and Food Research2005;49:601‐8. ">Galvez 2005</a>). In IBD mouse models, high‐fat diets promote further intestinal inflammation by disrupting gut barrier function and the resident microbiome (<a href="./references#CD012839-bbs2-0077" title="DevkotaS , WangY , MuschMW , LeoneV , Fehlner‐PeachH , NadimpalliA , et al. Dietary‐fat‐induced taurocholic acid promotes pathobiont expansion and colitis in Il10‐/‐ mice. Nature2012;487:104‐8. ">Devkota 2012</a>; <a href="./references#CD012839-bbs2-0084" title="GruberL , KislingS , LichtiP , MartinFP , MayS , KlingensporM , et al. High fat diet accelerates pathogenesis of murine Crohn's disease‐like ileitis independently of obesity. PLoS One2013;8:e71661. ">Gruber 2013</a>; <a href="./references#CD012839-bbs2-0117" title="van derLogtEM , BlokzijlT , van derMeerR , FaberKN , DijkstraG . Westernized high‐fat diet accelerates weight loss in dextran sulfate sodium‐induced colitis in mice, which is further aggravated by supplementation of heme. Journal of Nutritional Biochemistry2013;24:1159‐65. ">van der Logt 2013</a>). Similarly, one of the theories underlying the efficacy of exclusive enteral nutrition or elimination diets for induction of remission in IBD relates to an avoidance of dietary triggers. These pro‐ or anti‐inflammatory nutrients are thus suspected to confer respective pro‐ or anti‐inflammatory properties of diets. Others have hypothesized that people with IBD may possess individualized food sensitivities and disease activity could improve with the personalized exclusion of foods that provoke symptoms or cause abnormal increases in food‐specific IgG antibodies (<a href="./references#CD012839-bbs2-0021" title="BentzS , HausmannM , PibergerH , KellermeierS , PaulS , HeldL , et al. Clinical relevance of IgG antibodies against food antigens in Crohn's disease: a double‐blind cross‐over diet intervention study. Digestion2010;81(4):252‐64. [PUBMED: 20130407] ">Bentz 2010</a>; <a href="./references#CD012839-bbs2-0030" title="GunasekeeraV , MendallMA , ChanD , KumarD . Treatment of Crohn's disease with an IgG4‐guided exclusion diet: a randomized controlled trial. Digestive Diseases and Sciences2016;61(4):1148‐57. [PUBMED: 26809868] ">Gunasekeera 2016</a>; <a href="./references#CD012839-bbs2-0110" title="RajendranN , KumarD . Food‐specific IgG4‐guided exclusion diets improve symptoms in Crohn's disease: a pilot study. Colorectal Disease2011;13:1009‐13. ">Rajendran 2011</a>), although food‐specific IgG antibodies have not been found to correlate with gastrointestinal symptom severity (<a href="./references#CD012839-bbs2-0118" title="ZuoXL , LiYQ , LiWJ , GuoYT , LuXF , LiJM , et al. Alterations of food antigen‐specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia. Clinical and Experimental Allergy2007;37(6):823‐30. ">Zuo 2007</a>). The elimination of foods that are high in short‐chain carbohydrates (i.e. FODMAP: Fermentable Oligo‐, Di‐, Monosaccharides, And Polyols) may improve CD symptoms through several possible mechanisms including reduction of gaseous byproducts of bacterial fermentation, gaseous distention, osmotic diarrhoea, and shifts in the gut microbiome (<a href="./references#CD012839-bbs2-0081" title="GearryRB , IrvingPM , BarrettJS , NathanDM , ShepherdSJ , GibsonPR . Reduction of dietary poorly absorbed short‐chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease‐a pilot study. Journal of Crohn's and Colitis2009;3:8‐14. ">Gearry 2009</a>; <a href="./references#CD012839-bbs2-0082" title="GibsonPR , VarneyJ , MalakarS , MuirJG . Food components and irritable bowel syndrome. Gastroenterology2015;148:1158‐74. ">Gibson 2015</a>; <a href="./references#CD012839-bbs2-0087" title="HalmosEP , ChristophersenCT , BirdAR , ShepherdSJ , GibsonPR , MuirJG . Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut2015;64:93‐100. ">Halmos 2015</a>; <a href="./references#CD012839-bbs2-0031" title="E. P.Halmos , C. T.Christophersen , A. R.Bird , S. J.Shepherd , J. G.Muir , P. R.Gibson . Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn’s Disease: A Randomised, Controlled Cross‐Over Trial of Well‐Defined Diets. Clinical and Translational Gastroenterology2016;7:e164. ">Halmos 2016</a>; <a href="./references#CD012839-bbs2-0109" title="PrinceAC , MyersCE , JoyceT , IrvingP , LomerM , WhelanK . Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases2016;22:1129‐36. ">Prince 2016</a>; See <a href="#CD012839-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD012839-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Source: Mullin 2016." data-id="CD012839-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Source: <a href="./references#CD012839-bbs2-0102" title="MullinGE . Role of diet in Inflammatory Bowel Disease. Presented at: Digestive Disease Week; May 2016; San Diego, CA. ">Mullin 2016</a>. </p> </div> </div> </div> </section> <section id="CD012839-sec-0041"> <h3 class="title" id="CD012839-sec-0041">Why it is important to do this review</h3> <p>Patients and clinicians have long sought guidance on the dietary management of IBD. A prospective evaluation of 400 consecutive IBD patients at a tertiary‐care center reported that approximately half felt that diet could be the initiating factor in their disease and the majority cited food provocation of IBD symptoms (57%) and disease flares (60%) (<a href="./references#CD012839-bbs2-0097" title="LimdiJK , AggarwalD , McLaughlinJT . Dietary Practices and Beliefs in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases2016;22:164‐70. ">Limdi 2016</a>). Several 'brand' diets (e.g. Specific Carbohydrate Diet, gluten‐free diet, Anti‐Inflammatory Diet, Gut and Psychology Diet) are promoted on the internet by healthcare practitioners and even non‐licensed individuals, often without supporting evidence. These diet programs restrict, exclude, or promote the intake of differing food types to achieve purported improvements in IBD symptoms. Several clinical trials and observational cohort studies have studied the effects of diverse diets on clinical endpoints in IBD. Nonetheless, the individual studies are often limited by small sample sizes, suboptimal study design, and inconsistent findings. Despite several opinion papers and reviews on the issue of dietary management of IBD, there is still no consensus or clear guidance in the literature on optimal dietary therapies for induction or maintenance of remission in IBD. A systematic review is lacking and could potentially benefit both clinicians and patients to guide dietary management of IBD based on the best available evidence. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012839-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012839-sec-0042">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012839-sec-0139">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012839-sec-0042"></div> <p>The objective of this systematic review is to evaluate the efficacy and safety of dietary interventions on IBD outcomes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012839-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012839-sec-0043">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012839-sec-0140">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012839-sec-0043"></div> <section id="CD012839-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012839-sec-0045"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials (RCTs) were considered for inclusion.</p> </section> <section id="CD012839-sec-0046"> <h4 class="title">Types of participants</h4> <p>Adults or children with established IBD (CD, UC) were considered for inclusion. For studies that only reported on IBD, we contacted the authors to request a breakdown of results for participants with CD and UC. Trials conducted in all settings (e.g. single‐center, multi‐center) with any established method used to confirm disease diagnosis were included. Studies were not included unless stratified results for IBD (CD and UC) were provided. </p> </section> <section id="CD012839-sec-0047"> <h4 class="title">Types of interventions</h4> <p>Interventions of interest included all defined oral diets compared to a different or unrestricted oral diet. Studies that exclusively focused on enteral nutrition, oral nutrient supplementation, medical foods, probiotics, and parenteral nutrition were excluded. </p> </section> <section id="CD012839-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD012839-sec-0049"> <h5 class="title">Primary outcomes</h5> <p>Primary outcomes were induction and maintenance of remission as defined by the included studies. </p> <p> <ol id="CD012839-list-0001"> <li> <p>Induction of remission involves the therapeutic reduction of intestinal symptoms below a clinical threshold as measured by CD and UC symptom scores, including the Pediatric Crohn’s Disease Activity Index (PCDAI), the Crohn’s Disease Activity Index (CDAI), the Harvey‐Bradshaw Index (HBI), the Mayo score, modified Mayo score or Colitis Activity Index (CAI). </p> </li> <li> <p>Maintenance of remission involves the continual abatement of symptoms over time attributable to a therapeutic modality (in this case, diet). Maintenance of remission will be assessed based on available fixed time intervals (e.g. six months, one year) and as variable time contributions (e.g. person‐years). A clinical relapse is defined as the transition from a state of clinical remission to active disease, based on symptom scores (i.e. PCDAI, CDAI, HBI, Mayo score, or CAI). </p> </li> </ol> </p> <p>Although symptom scores are validated indices routinely used to assess disease activity in IBD clinical trials, a potential limitation is the inability to differentiate between IBD or irritable bowel syndrome (IBS)‐associated mediators of non‐specific gastrointestinal symptoms. </p> </section> <section id="CD012839-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes (when available) were the following:</p> <p> <ol id="CD012839-list-0002"> <li> <p>Clinical improvement as defined by the included studies;</p> </li> <li> <p>Corticosteroid‐free remission;</p> </li> <li> <p>Surrogate biomarkers of inflammation (i.e., erythrocyte sedimentation rate [ESR] and C‐reactive protein [CRP]), fecal biomarkers (i.e., calprotectin); </p> </li> <li> <p>Endoscopic endpoints of improvement and remission;</p> </li> <li> <p>Histologic endpoints of improvement and remission;</p> </li> <li> <p>Health‐related quality of life as measured by the Inflammatory Bowel Disease Questionnaire (IBDQ), Short Inflammatory Bowel Disease Questionnaire (SIBDQ), or related surveys; </p> </li> <li> <p>Hospitalizations;</p> </li> <li> <p>Need for surgery;</p> </li> <li> <p>Progression of disease from a state of inflammation‐only disease to stricturing/obstructing to penetrating/fistulizing disease; </p> </li> <li> <p>Escalation of therapy including the need to add or modify pharmacologic therapy due to lack of efficacy at inducing or maintaining remission after enrollment in the trial; </p> </li> <li> <p>Adverse events;</p> </li> <li> <p>Withdrawal due to adverse events; and</p> </li> <li> <p>Serious adverse events.</p> </li> </ol> </p> </section> </section> </section> <section id="CD012839-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012839-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We conducted a comprehensive and systematic search to identify RCTs and non‐randomized studies (i.e. cohort or case‐control) from inception to 31 January 2019 using the following databases: </p> <p> <ul id="CD012839-list-0003"> <li> <p>CENTRAL;</p> </li> <li> <p>Cochrane IBD Group Specialized Trials Register;</p> </li> <li> <p>Embase (Ovid)<i>;</i> </p> </li> <li> <p>MEDLINE (Ovid<i>)</i>; and </p> </li> <li> <p>Web of Science.</p> </li> </ul> </p> <p>We searched databases using controlled vocabulary and keywords (details in appendices). No restrictions were placed on publication dates (after 1966) or language. Note that the searches were designed to include interventional and observational studies on adults and children but exclude those using oral nutrition supplements (enteral nutrition drinks, tube feeds), medical foods, probiotics, parenteral nutrition or a combination of these modalities. We report the detailed search strategies in <a href="./appendices#CD012839-sec-0122">Appendix 1</a>. </p> </section> <section id="CD012839-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists from included articles and any existing relevant reviews. We also scanned proceedings from Digestive Disease Week (2005 to date), Advances in Inflammatory Bowel Disease (2005 to date), Clinical Nutrition Week (2005 to date), European Crohn's and Colitis Organisation (2005 to date), and United European Gastroenterology Week (2005 to date). We also searched ongoing trials registered in ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform portal. </p> </section> </section> <section id="CD012839-sec-0054"> <h3 class="title" id="CD012839-sec-0054">Data collection and analysis</h3> <p>This review has been carried out according to methods presented in the published protocol (<a href="./references#CD012839-bbs2-0119" title="LimketkaiBN , ParianA , KoretzRL , NanavatiJE , ShinoharaRT , MullinGE . Dietary interventions for induction and maintenance of remission in inflammatory bowel disease. Cochrane Database of Systematic Reviews2017, Issue 10. [DOI: 10.1002/14651858.CD012839] ">Limketkai 2017</a>), which are based on the Cochrane Handbook (<a href="./references#CD012839-bbs2-0089" title="HigginsJP , GreenS . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. ">Higgins 2011</a>). </p> <section id="CD012839-sec-0055"> <h4 class="title">Selection of studies</h4> <p>The stages of article selection included the following: (i) title screening; (ii) abstract screening; and (iii) full‐text review. Two authors (BNL and GEM) independently reviewed each article at each stage of selection. Included and excluded studies were recorded. </p> <p> <ol id="CD012839-list-0004"> <li> <p>Title screening involved selection of articles that reported studies with even a minor possibility of inclusion. Articles that are clearly unrelated were excluded. Adjudication did not occur at the title screening stage and ambiguous studies were included by default. </p> </li> <li> <p>Abstract screening involved the selection of articles that reported studies with a reasonable possibility of inclusion. Differences in assessment for inclusion were resolved by discussion between the two independent investigators. Adjudication did not occur at the abstract screening state and studies that were ambiguous were included by default. </p> </li> <li> <p>Full‐text review involved selection of articles based on careful examination of the full report. Differences in assessment for inclusion were resolved by discussion between the two independent investigators. Adjudication was performed as needed by a third author (AP). </p> </li> </ol> </p> </section> <section id="CD012839-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>Two authors (TH and ZIE) independently performed data extraction from each included study. Any discrepancies were resolved by discussion between the two independent investigators. Adjudication was performed as needed by a third author (MG). Extracted data included the study design, population characteristics, intervention, comparator, duration of interventions and follow‐up, outcomes, timing, setting, the method of handling missing data, funding source, and potential conflicts of interest. </p> </section> <section id="CD012839-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (TH and ZIE) independently assessed the study quality of each included RCT using the Cochrane risk of bias tool. Adjudication was performed as needed by a third author (MG). Domains of interest included random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, completeness of outcome data, selective reporting, and other potential sources of bias (e.g. baseline imbalance). Each domain was assessed as having a low, moderate, high, or unclear risk of bias. Based on the aggregate assessment of these items, study quality was rated as good (low risk of bias), fair, or poor (high or unclear risk of bias). Each domain followed standard definitions used for Cochrane systematic reviews (<a href="./references#CD012839-bbs2-0089" title="HigginsJP , GreenS . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. ">Higgins 2011</a>). </p> <p>We considered trials which were classified as having a low risk of bias for sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, completeness of outcome data, and selective reporting as low bias‐risk trials. All other trials were considered to be at high risk of bias. We tabulated the risk of bias in the 'Risk of bias' table as part of the 'Table of characteristics of included studies'. We also illustrated the risk of bias of each trial using the 'Risk of bias summary' and cross‐tabulated all the judgement of risk on a 'Risk of bias graph'. </p> <p>The overall strength of evidence supporting the primary outcome and selected secondary outcomes was assessed using the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) criteria (<a href="./references#CD012839-bbs2-0085" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. ">Guyatt 2008</a>; <a href="./references#CD012839-bbs2-0113" title="SchünemannHJ , OxmanAD , VistGE , HigginsJPT , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>). Evidence from RCTs starts as high quality and evidence from observational studies starts as low quality. The quality of the evidence can be downgraded due to risk of bias, indirect evidence, inconsistency (unexplained heterogeneity), imprecision; and publication bias. GRADE also allows for the potential of rating up the overall quality of evidence from methodologically sound observational studies (<a href="./references#CD012839-bbs2-0086" title="GuyattGH , OxmanAD , SultanS , GlasziouP , AklEA , Alonso‐CoelloP , et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology2011;64(12):1311‐6. ">Guyatt 2011</a>). For example, evidence could be rated up if high quality observational studies show a two‐ to five‐fold reduction or increase in risk (<a href="./references#CD012839-bbs2-0086" title="GuyattGH , OxmanAD , SultanS , GlasziouP , AklEA , Alonso‐CoelloP , et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology2011;64(12):1311‐6. ">Guyatt 2011</a>). Taking all of these factors into account, we rated the overall quality of evidence as follows: </p> <p> <ol id="CD012839-list-0005"> <li> <p>High. We are very confident that the true effect lies close to that of the estimate of the effect; </p> </li> <li> <p>Moderate. We are moderately confident in the effect estimate. The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; </p> </li> <li> <p>Low. Our confidence in the effect estimate is limited. The true effect may be substantially different from the estimate of the effect; or </p> </li> <li> <p>Very low. We have very little confidence in the effect estimate. The true effect is likely to be substantially different from the estimate of effect. </p> </li> </ol> </p> </section> <section id="CD012839-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>For binary outcomes, we calculated the risk ratio (RR) with corresponding 95% confidence interval (CI). For nominal or ordinal outcomes, we planned to calculate the RR with corresponding 95% CI for each category relative to a reference category. For continuous outcomes, we calculated the mean difference (MD) and corresponding 95% CI. </p> </section> <section id="CD012839-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant. We planned to include cross‐over trials if data were available from the first phase of the study (i.e. before cross‐over occurred). For outcomes where events recur (e.g. clinical relapses, adverse events), we calculated the proportion of patients who experienced at least one event, individual events were not counted separately. The studies were otherwise not anticipated to have repeated observations of outcomes or multiple treatment events. Ecologic studies that did not include individual‐level intervention and analyses were to be excluded. For studies with multiple treatment arms, we only included single pair‐wise comparisons as appropriate. </p> </section> <section id="CD012839-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We collected information on how each trial handled missing data. When a study appeared to collect and not report all primary outcomes of interest, the original investigators were contacted to request missing data. If the original investigators did not provide the data, this would be noted in the systematic review. For studies with missing dichotomous data, a separate intention‐to‐treat analysis was performed where participants with missing data were assumed to have been treatment failures. For studies with missing continuous data, we used of available cases and imputation with the last observation carried forward. Multiple imputation was to be applied to missing data. </p> </section> <section id="CD012839-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was first assessed qualitatively considering the study populations (e.g. adults, children, age, sex, race), research setting, methods of dietary interventions, duration of interventions, and definitions and thresholds for remission. For studies that had qualitative homogeneity, statistical heterogeneity was assessed using the Chi² test (P value &lt; 0.10 was considered statistically significant heterogeneity). The degree of heterogeneity across studies was estimated using the I² statistic. An I² of 25% or less was considered low heterogeneity, 26 to 50% was considered moderate heterogeneity, and 50% and greater was considered substantial heterogeneity. We planned to only report on summary effect estimates from meta‐analyses of groups of studies with clinical, methodologic, and statistical homogeneity (i.e. I² &lt; 50%). Additionally, we visually inspected the forest plots and planned to perform a sensitivity analysis excluding any obvious outliers. </p> </section> <section id="CD012839-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>The total number of registered trials that could qualify for inclusion if published were to be compared against the number of peer‐reviewed publications. Study contacts for registered trials without a peer‐reviewed publication were to be contacted to assess reasons for the absence of publication. If 10 of more studies were included in the meta‐analysis, a funnel plot would have been used to assess for potential publication bias. </p> </section> <section id="CD012839-sec-0063"> <h4 class="title">Data synthesis</h4> <p>This systematic review qualitatively reported on the included study characteristics and outcomes. We conducted a meta‐analysis of studies where at least two studies with similar interventions, participants and reported outcomes were present (to be determined by consensus). Analyses were performed separately according to disease type (CD or UC), population (adult or pediatric), and type of diet. For dichotomous outcomes, we calculated the pooled RR and corresponding 95% CI. For continuous outcomes, we calculated the pooled MD and corresponding 95% CI. Studies were pooled using a random‐effects model. Studies were grouped according to disease state (active or inactive) and type (UC or CD). </p> </section> <section id="CD012839-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to qualitatively evaluate the usage patterns of concurrent IBD‐specific therapies (e.g. antibiotics, aminosalicylates, immunomodulators, biologics) in the study populations. Where possible, subgroup analyses were to be performed based on therapy classes. </p> </section> <section id="CD012839-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses that exclude studies with high risk of bias. However, as over 70% of the studies were at high risk of bias, there would have been little or no data to assess in a sensitivity analysis </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012839-sec-0066" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012839-sec-0066"></div> <section id="CD012839-sec-0067"> <h3 class="title">Description of studies</h3> <section id="CD012839-sec-0068"> <h4 class="title">Results of the search</h4> <p>The literature search identified 8097 records which was reduced to 7166 unique records following the removal of duplicates. Titles and abstracts were screened and we initially identified 60 studies which appeared to meet the inclusion criteria. Full text copies of these 60 studies were obtained and further scrutinised. After reviewing full text articles, we excluded 35 studies which had the wrong study design, participants, interventions or outcomes. We included 18 studies with a total of 1878 participants in our systematic review. We also identified five ongoing studies with an estimated enrollment of 498 participants (See <a href="./references#CD012839-sec-0133" title="">Characteristics of ongoing studies</a>) and two studies awaiting classification (<a href="./references#CD012839-bbs2-0054" title="BodiniG , GianniniEGB , SavarinoV , CrespiM , Lo PumoS , ZanellaC , et al. Low FODMAP diet improve disease activity and quality of life in patients with inflammatory bowel disease. Digestive and Liver Disease2018;50:e197‐8. ">Bodini 2018</a>; <a href="./references#CD012839-bbs2-0055" title="TapeteG , DeBortoliN , CeccarelliL , MumoloMG , VinciE , AlbanoE , et al. Low‐FODMAPs diet improves intestinal symptoms in IBD patients with disease remission: Randomized case‐control study. Digestive and Liver Disease2018;50:e195. ">Tapete 2018</a>). The results of the search are reported in the PRISMA flow diagram (See <a href="#CD012839-fig-0002">Figure 2</a>). Full details of the included and excluded studies are available in the <a href="./references#CD012839-sec-0130" title="">Characteristics of included studies</a> and <a href="./references#CD012839-sec-0131" title="">Characteristics of excluded studies</a> tables and are summarised below. </p> <div class="figure" id="CD012839-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012839-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012839-sec-0069"> <h4 class="title">Included studies</h4> <section id="CD012839-sec-0070"> <h5 class="title">Study design and setting</h5> <p>The included studies were conducted in single or multi centers across eight different countries and were published between 1965 and 2018. Thirty‐five per cent of the studies were conducted in the UK (<a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>), 23% in the USA (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>), 11% in Germany (<a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>), 11% in Italy (<a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>) and the rest were conducted in Austria (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>), Canada (<a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>), Israel (<a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>), and South Africa (<a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>). </p> </section> <section id="CD012839-sec-0071"> <h5 class="title">Participants</h5> <p>The 18 studies included a total of 1878 randomized participants with sample sizes ranging between 7 and 659 participants. Disease severity was reported as mild, or mild to moderate in two studies (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>). The other studies did not report on disease severity. The use of medication was apparent in some or all participants in almost half of the studies regardless of disease type or state. However, this information was not reported in the rest of the studies. The age of participants was reported in all except two studies (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>), and ranged between an average of 11.2 years to 48 years across 12 studies. Other studies reported age as median (<a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>), or range (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>). One study recruited only paediatric patients (<a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>), and the rest of the studies appear to have included mainly adults. The studies looked at people with the following disease states and types: </p> <p> <ul id="CD012839-list-0006"> <li> <p>Active Crohn's disease (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>); </p> </li> <li> <p>Inactive Crohn's disease (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>); </p> </li> <li> <p>Active ulcerative colitis (<a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>); and </p> </li> <li> <p>Inactive ulcerative colitis (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). </p> </li> </ul> </p> </section> <section id="CD012839-sec-0072"> <h5 class="title">Interventions</h5> <p>All the included studies had two trial arms, except four studies with more than two trial arms (<a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016;</a><a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). The studies compared intervention diets with control diets. For the purpose of this review, 'intervention diet' has been used to describe diets involving the consumption of low levels or complete exclusion of one or more food groups that are thought to trigger symptoms of IBD (see <a href="#CD012839-sec-0038">Description of the condition</a>). Control diets involved normal amounts these food groups which were restricted in the intervention group, other diet modifications or advice. From <a href="#CD012839-tbl-0006">Table 2</a> it is apparent that whilst some dietary modifications were centred around single food groups, other diets seemed to involve multiple food groups. These interventions and controls are summarised as follows: </p> <div class="table" id="CD012839-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of interventions and outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group 1 (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group 2 (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group 3 (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group 4 (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Induction of Remission in Crohn's Disease</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Restricted organic diet (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low‐fat, high‐carbohydrate, low‐fiber, no red meat diet (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/5 vs. 7/9 (week 6)</p> <p>PP:4/5 vs. 5/9 (week 24)</p> <p>ITT: 4/8 vs. 5/10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High‐fiber, reduced refined carbohydrate diet (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low‐fiber diet (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Remission: 4/4 vs. 0/3 (week 4)</p> <p>Change in pHBI: 5.8 to 0.5 vs. 5.2 to 3.5 (<i>P</i> = 0.008) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sequential elimination diets for 30 food components (32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Conventional nutritional advice (19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response: 16/32 vs. 1/19</p> <p>Remission: 16/32 vs. 0/19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low fiber diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal diet (with gradual fiber introduction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diet low in microparticles. Fibrous fruit and vegetables were excluded (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Foods containing dietary microparticles were not discouraged. Fibrous fruit and vegetables were excluded (10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PP: 7/9 vs. 0/9 (month 4)</p> <p>ITT: 7/10 vs. 0/10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low calcium and low microparticle diet (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low calcium and normal microparticle diet (21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal calcium and low microparticle diet (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal calcium and normal microparticle diet (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low vs. normal microparticle groups.</p> <p>Response: 16/42 vs. 17/41 (week 16)</p> <p>Remission: 16/42 vs. 13/41 (week 16)</p> <p>Low versus normal calcium</p> <p>Remission:</p> <p>16/43 versus 13/40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Maintenance of Remission in Crohn's Disease</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low red and processed meats (96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate red and processed meats (118)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54/87 vs. 72/115 (week 48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low carbohydrate diet with increased intake of protein and fat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High carbohydrate diet with reduced intake of protein and fat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/5 vs. 1/6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exclusion of foods that provoked symptoms (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unrefined carbohydrate fiber‐rich diet (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/10 vs. 10/10 (month 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low‐carbohydrate diet of less than 84 g/day (69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Omega‐3 fatty acid capsules and general nutrition guidelines (70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo and general nutrition guidelines (65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45/69 vs. 50/70 vs. 46/65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anti‐IBD diet and placebo supplement (16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fructooligosaccharide supplement and "placebo diet" (19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Placebo diet" and placebo supplement (19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/16 vs. 6/19 vs. 4/19 (month 12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elemental diet followed by reintroduction of single food each day and exclusion of symptom‐provoking foods (40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>General dietary advice and prednisolone taper (38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PP: 12/40 vs. 25/38 (month 24)</p> <p>ITT: 21/40 vs. 30/38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unrefined, fiber‐rich diet (190)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Refined carbohydrate‐rich diet and unrestricted sugar intake (162)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>130/190 vs. 96/162 (month 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Induction of Remission in Ulcerative Colitis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Systematic exclusion of symptoms‐provoking foods (11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual diet (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response: 9/11 vs. 1/7 (week 6)</p> <p>Remission: 4/11 vs. 0/7 (week 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Maintenance of Remission in Ulcerative Colitis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Carrageenan‐free diet + placebo (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Carrageenan‐free diet + carrageenan‐containing capsules (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PP: 0/7 vs. 3/5 (month 12)</p> <p>ITT: 3/10 vs. 3/5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alberta‐based Anti‐inflammatory Diet (14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diet based on Canada's Food Guide (14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/14 vs. 4/14 (month 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cow’s milk protein elimination diet (14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual diet (15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/13 vs. 4/15 (month 6)</p> <p>7/13 vs. 8/15 (month 12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Milk‐free, low‐roughage diet (26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exclusion diet and liberal consumption of milk and milk products (24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/26 vs. 18/23 (month 12)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: ITT, Intention‐to‐treat; N/A, not applicable; pHBI, partial Harvey‐Bradshaw Index; PP, per‐protocol </p> </div> </div> <p> <ul id="CD012839-list-0007"> <li> <p>Low refined carbohydrate diets (<a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>). The control diets were either intentionally rich in refined carbohydrates (<a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>), or provided no guidance on carbohydrate intake (<a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>). </p> </li> <li> <p>Low microparticle diets (<a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>). The control diets included a sham diet that avoided other food additives (i.e., sulphur dioxide and sulphites) and added 5 mg/day titanium dioxide (TiO<sub>2</sub>). Toothpaste that was free of TiO<sub>2</sub>, but not particulate silicates, was provided. </p> </li> <li> <p>Low calcium diet (<a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>). The control diet included a calcium supplement of 400 mg/day. </p> </li> <li> <p>Low red, processed meat diet (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>). The control diet included a minimum of two servings per week of red meat. </p> </li> <li> <p>Low disaccharides, grains, saturated fats, red and processed meat diet (<a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>). The control diet was undefined, but presumably included the opposite composition of the intervention. </p> </li> <li> <p>Symptoms‐guided diets (<a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>). The controls arms included a high fiber diet (<a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>), undefined 'conventional' dietary advice (<a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>), no dietary modification (<a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>), and corticosteroids (<a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>). </p> </li> <li> <p>Highly restricted organic diet (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>). The control diet included a low‐fat, low‐fiber, high‐carbohydrate diet. </p> </li> <li> <p>Milk‐free diets (<a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). The control diets included an unrestricted diet (<a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>), or the exclusion of certain food items, such as fried foods, condiments, and ice cream (<a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). </p> </li> <li> <p>Alberta‐based anti‐inflammatory diet (<a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>). The control diet included recommendations from the Canada Food Guide. </p> </li> <li> <p>Carrageenan‐free diet (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>). The control diet included 100 mg of encapsulated food‐grade carrageenan with each meal (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>). </p> </li> </ul> </p> <p>After randomisation, dietary instruction was provided by a dietitian or other research personnel in most studies (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). Dietary instruction was primarily provided by written materials in three studies (<a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>), and advice was provided through unclear mechanisms in four studies (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>). </p> <p>In studies which provided some description, the intervention regimen varied and there was very little information on food groups which participants were exposed to other than the study intervention. The specific proportions or concentrations of macro‐ and micronutrients consumed at baseline or after randomisation were not reported. Nonetheless, adherence to dietary recommendations was monitored through periodic interviews in most studies (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>). The method for assessing dietary adherence was not reported in six studies (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>). </p> <p>The use of concomitant treatments was discussed in eight studies with six studies reporting the use of medication (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>), one study indicating that drug treatment was omitted 14 days before the study commenced (<a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>), and one study which administered prednisolone in the control arm which was gradually withdrawn over the course of the study (<a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>). There was no mention of concomitant treatments in the rest of the studies. </p> </section> <section id="CD012839-sec-0073"> <h5 class="title">Outcomes</h5> <p>Participants were followed up for 1 to 24 months. Outcomes of interest reported in the studies were: </p> <p> <ul id="CD012839-list-0008"> <li> <p>Induction of remission (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>); </p> </li> <li> <p>Clinical relapse (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>); </p> </li> <li> <p>Surrogate biomarkers of inflammation (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>); </p> </li> <li> <p>Endoscopic improvement (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>); </p> </li> <li> <p>Histologic improvement (<a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>); </p> </li> <li> <p>Health‐related quality of life (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>); </p> </li> <li> <p>Need for surgery (<a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>); </p> </li> <li> <p>Progression of disease (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>); and </p> </li> <li> <p>Escalation of therapy (<a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>). </p> </li> </ul> </p> </section> <section id="CD012839-sec-0074"> <h5 class="title">Funding and declaration of interest</h5> <p>Seventy‐two per cent of the included studies reported no information on both funding sources and declarations of interest (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). In two studies, authors had no conflicts of interest, however, funding was not reported (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>). Three studies were funded by a stipend from a University (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>), or grants from government organizations (<a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>), however, the authors of these studies did not declare any financial interests. </p> </section> </section> <section id="CD012839-sec-0075"> <h4 class="title">Excluded studies</h4> <p>Thirty‐five studies were excluded for reasons which are detailed in the <a href="./references#CD012839-sec-0130" title="">Characteristics of included studies</a> tables and summarised below: </p> <p> <ul id="CD012839-list-0009"> <li> <p>Twelve excluded studies had the wrong study design (<a href="./references#CD012839-bbs2-0019" title="BarnesEL , NestorMA , OnyewadumeL , deSilvaPS , KorzenikJR . A prospective study: the role of diet in exacerbations of patients with ulcerative colitis in remission on monotherapy with mesalamine. Gastroenterology2016;150(4):S5‐6. ">Barnes 2016</a>; <a href="./references#CD012839-bbs2-0020" title="BeattieRM , Walker‐SmithJA . Treatment of active Crohn's disease by exclusion diet. Journal of Pediatric Gastroenterology and Nutrition1994;19(1):135‐6. [PUBMED: 7965469] ">Beattie 1994</a>; <a href="./references#CD012839-bbs2-0023" title="BrandesJW , KörstHA , LittmanKP . Sugar‐free diet as long‐term or interval treatment in the remission phase of Crohn disease ‐ a prospective study. Leber Magen Darm1982;12(6):225‐8. [PUBMED: 6135129] ">Brandes 1982</a>; <a href="./references#CD012839-bbs2-0024" title="CastroM , LucidiV , ColomboAM , GambararaM . Diet therapy or drug therapy in Crohn's disease. Rivista Italiana Di Pediatria1995;21(4):439‐45. ">Castro 1995</a>; <a href="./references#CD012839-bbs2-0025" title="CiccimarraE , BorrelliO , FrancoMT , IulaVD , MontisciA , DeViziaB , et al. Nutritional therapy of Crohn's disease. Rivista Italiana Di Pediatria1998;24(1):108‐16. ">Ciccimarra 1998</a>; <a href="./references#CD012839-bbs2-0026" title="CohenSA , StallworthAN , KochBM , MasonDH , BlumenthalJ , GoldBD . Mucosal healing with the Specific Carbohydrate Diet in pediatric Crohn's disease: preliminary results of a prospective pilot study. Gastroenterology2012;142(5):S376. ">Cohen 2012</a>; <a href="./references#CD012839-bbs2-0027" title="DaviesPS , RhodesJ . Maintenance of remission in ulcerative colitis with sulphasalazine or a high‐fibre diet: a clinical trial. British Medical Journal1978;1(6126):1524‐5. [PUBMED: 26448] ">Davies 1978</a>; <a href="./references#CD012839-bbs2-0031" title="E. P.Halmos , C. T.Christophersen , A. R.Bird , S. J.Shepherd , J. G.Muir , P. R.Gibson . Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn’s Disease: A Randomised, Controlled Cross‐Over Trial of Well‐Defined Diets. Clinical and Translational Gastroenterology2016;7:e164. ">Halmos 2016</a>, <a href="./references#CD012839-bbs2-0038" title="NCT02345733 . Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis. ClinicalTrials.gov/show/NCT02345733 (accessed 31 January 2018). ">NCT02345733</a>; <a href="./references#CD012839-bbs2-0043" title="NCT02922881 . Microbiota‐targeted Diet for Pediatric UC (UCD). ClinicalTrials.gov/show/NCT02922881 (accessed 31 January 2018). ">NCT02922881</a>; <a href="./references#CD012839-bbs2-0046" title="NCT03171246 . CD‐TREAT Diet: a Novel Therapy for Active Luminal Crohn's Disease. ClinicalTrials.gov/show/NCT03171246 (accessed 31 January 2018). ">NCT03171246</a>; <a href="./references#CD012839-bbs2-0049" title="Pituch‐ZdanowskaA , AlbrechtP , BanasiukM , BanaszkiewiczA . Dietary fiber intake in children with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition2018;66:624‐9. ">Pituch‐Zdanowska 2018</a>). </p> </li> </ul> <ul id="CD012839-list-0010"> <li> <p>Six studies either assessed a mixed population and did not report outcomes by sub‐population (<a href="./references#CD012839-bbs2-0030" title="GunasekeeraV , MendallMA , ChanD , KumarD . Treatment of Crohn's disease with an IgG4‐guided exclusion diet: a randomized controlled trial. Digestive Diseases and Sciences2016;61(4):1148‐57. [PUBMED: 26809868] ">Gunasekeera 2016</a>; <a href="./references#CD012839-bbs2-0048" title="PedersenN , AnkersenDV , FeldingM , WachmannH , VéghZ , MolzenL , et al. Low‐FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World Journal of Gastroenterology2017;23(18):3356‐66. [PUBMED: 28566897] ">Pedersen 2017</a>; <a href="./references#CD012839-bbs2-0050" title="StangeEF , SchmidU , FleigWE , DitschuneitH . Exclusion diet in Crohn disease: a controlled, randomized study. Zeitschrift fur Gastroenterologie1990;28(10):561‐4. [PUBMED: 2275253] ">Stange 1990</a>), or assessed IBS (<a href="./references#CD012839-bbs2-0053" title="VincenziM , PaoliniB , DelCiondoloI , PasquiniE , CeccarelliL , GennaiK , et al. Effects on symptoms and on nutritional adequacy of a low FODMAPs diet and Specific Carbohydrate Diet on inflammatory bowel disease. Double blind and randomized study. Preliminary result. Gastroenterology2016;150(4):S425. ">Vincenzi 2016</a>), healthy participants (<a href="./references#CD012839-bbs2-0040" title="NCT02426567 . The Impact of &quot;Crohn's Disease‐TReatment‐with‐EATing&quot; Diet and Exclusive Enteral Nutrition on Healthy Gut Bacteria. ClinicalTrials.gov/show/NCT02426567 (accessed 31 January 2018). ">NCT02426567</a>) or failed to provide sufficient information on baseline disease activity (<a href="./references#CD012839-bbs2-0032" title="KyawMH , MoshkovskaT , MayberryJ . A prospective, randomized, controlled, exploratory study of comprehensive dietary advice in ulcerative colitis: impact on disease activity and quality of life. European Journal of Gastroenterology &amp; Hepatology2014;26(8):910‐7. [PUBMED: 24942954] ">Kyaw 2014</a>). </p> </li> </ul> <ul id="CD012839-list-0011"> <li> <p>Five studies assessed the wrong interventions (<a href="./references#CD012839-bbs2-0022" title="Boneh , R.S , Shabat , C.S , Yanai , H , Chermesh , I , BenAvraham , S , Boaz , M , Levine , A . Dietary Therapy With the Crohn's Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy. Journal of Crohns &amp; ColitisOct 2017;11(10):1205‐1212. ">Boneh 2017</a>; <a href="./references#CD012839-bbs2-0028" title="DunnKA , BonehRS , BielawskiJP , TurnerD , VanLimbergenJE , LevineA . Crohn's disease exclusion diet and partial enteral nutrition (CDED+PEN) vs exclusive enteral nutrition (EEN) ‐ microbiome changes of a randomized clinical trial (RCT) in pediatric CD: Remission is associated with similar structural and functional profiles. Gastroenterology2017;152(5):S213. ">Dunn 2017</a>; <a href="./references#CD012839-bbs2-0029" title="El‐TahirA , HeysSD , SinclairT , MowatNAG , EwenS , EreminO . Effects of dietary supplementation on disease activity in patients with ulcerative colitis: a randomized controlled clinical study. British Journal of Surgery1998;85(11):1566. ">El‐Tahir 1998</a>; <a href="./references#CD012839-bbs2-0037" title="NCT02231814 . Pilot Study of Partial Enteral Nutrition With a Unique Diet for the Treatment of Adult Patients With Crohn's Disease. ClinicalTrials.gov/show/NCT02231814 (accessed 31 January 2018). ">NCT02231814</a>; <a href="./references#CD012839-bbs2-0051" title="StrohmWD , SteinhardtHJ , BrandesJW , JarnumS , LeonhardtH , EhmsH , et al. Low‐molecular fully balanced diets for the treatment of Crohn's disease ‐ a randomized controlled study. Zeitschrift fur Gastroenterologie1981;19(9):525. ">Strohm 1981</a>). </p> </li> </ul> <ul id="CD012839-list-0012"> <li> <p>Five of the excluded studies failed to assess outcomes of interest (<a href="./references#CD012839-bbs2-0021" title="BentzS , HausmannM , PibergerH , KellermeierS , PaulS , HeldL , et al. Clinical relevance of IgG antibodies against food antigens in Crohn's disease: a double‐blind cross‐over diet intervention study. Digestion2010;81(4):252‐64. [PUBMED: 20130407] ">Bentz 2010</a>; <a href="./references#CD012839-bbs2-0033" title="MikolaitisS , ChakradeoP , FoggL , KeshavarzianA , MutluE . Blinding of patients and physicians during a one‐year randomized clinical trial of dietary interventions for treatment of Crohn's disease. American Journal of Gastroenterology2013;108:S495. ">Mikolaitis 2013</a>; <a href="./references#CD012839-bbs2-0041" title="NCT02469220 . Diet Treatment of Patients With Ulcerative Colitis in Remission. ClinicalTrials.gov/show/NCT02469220 (accessed 31 January 2018). ">NCT02469220</a>; <a href="./references#CD012839-bbs2-0047" title="PedersenN , VindingKK , VeghZ , CasenC , AnkersenDV , CarlsenK , et al. Gut microbiota in IBD patients with IBS before and after 6 weeks of low FODMAP diet. Gastroenterology2014;146(5):S241. ">Pedersen 2014</a>; <a href="./references#CD012839-bbs2-0052" title="SvolosV , HansenR , KughesK , IjazUZ , QuinceC , GayaD , et al. The impact of 'Crohn's Disease‐TReatment‐with‐EATing' diet (CD‐TREAT diet) and exclusive enteral nutrition on healthy gut bacteria. Journal of Crohn's &amp; Colitis2016;10(Supplement 1):S14‐5. ">Svolos 2016</a>). </p> </li> </ul> <ul id="CD012839-list-0013"> <li> <p>Seven studies were excluded for other reasons such as lack of response from authors who were contacted for additional information (<a href="./references#CD012839-bbs2-0035" title='NCT02093780 . Personalized "Alberta" Diet for Prevention of Relapse in Ulcerative Colitis. ClinicalTrials.gov/show/NCT02093780 (accessed 31 January 2018). '>NCT02093780</a>; <a href="./references#CD012839-bbs2-0036" title="NCT02213835 . Treatment With the Specific Carbohydrate Diet for Children With Active Crohns Disease and Ulcerative Colitis. ClinicalTrials.gov/show/NCT02213835 (accessed 31 January 2018). ">NCT02213835</a>; <a href="./references#CD012839-bbs2-0039" title="NCT02357537 . Decentralized Dietary UC Pilot Trial. ClinicalTrials.gov/show/NCT02357537 (accessed 31 January 2018). ">NCT02357537</a>; <a href="./references#CD012839-bbs2-0042" title="NCT02610101 . Nutritional Therapy Study in Pediatric Crohn's Disease. ClinicalTrials.gov/show/NCT02610101 (accessed 31 January 2018). ">NCT02610101</a>; <a href="./references#CD012839-bbs2-0044" title="NCT02930564 . The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep Remission. ClinicalTrials.gov/show/NCT02930564 (accessed 31 January 2018). ">NCT02930564</a>), study abandonment (<a href="./references#CD012839-bbs2-0045" title="NCT02945488 . Exercise and Nutrition in IBD &amp; Preconception. ClinicalTrials.gov/show/NCT02945488 (accessed 31 January 2018). ">NCT02945488</a>) and study termination (<a href="./references#CD012839-bbs2-0034" title="NCT01749813 . Specific Carbohydrate Diet as Maintenance Therapy in Crohn's Disease. ClinicalTrials.gov/show/NCT01749813 (accessed 31 January 2018). ">NCT01749813</a>). </p> </li> </ul> </p> </section> </section> <section id="CD012839-sec-0076"> <h3 class="title">Risk of bias in included studies</h3> <p>Fourteen included studies were rated as high risk of bias for one or more items. Four studies were rated as unclear risk of bias for two or more items. Details of the risk of bias assessment have been presented in the <a href="./references#CD012839-sec-0130" title="">Characteristics of included studies</a> table and are summarised below (See <a href="#CD012839-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD012839-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012839-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012839-sec-0077"> <h4 class="title">Allocation</h4> <p>Thirteen of the included studies were rated as unclear risk of bias for failing to report methods used for random sequence generation and allocation concealment (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). One study was judged as being at high risk of bias for random sequence generation because a quasi‐randomized procedure (date of birth) was used to assign participants at one of the study centers (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>). Since allocation concealment is not feasible in quasi‐randomized trials, we also judged the study as being at high risk of bias for allocation concealment. Four studies were judged as being at low risk of bias for both sequence generation and unclear risk of bias for allocation concealment (<a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>). </p> </section> <section id="CD012839-sec-0078"> <h4 class="title">Blinding</h4> <p>We judged two studies as being at low risk of performance and detection bias (<a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>). Whilst <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a> was referred to as double blind and further details were not provided, we considered the information sufficient to make this judgement. </p> <section id="CD012839-sec-0079"> <h5 class="title">Performance bias</h5> <p>Nine studies which were not referred to as blinded were judged as being at high risk of performance bias. Four studies only provided information on the blinding of either the participants or study personnel but not both (<a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>). We judged five studies as being at low risk of bias for using some sort of 'dummy' diet or tablet (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). </p> </section> <section id="CD012839-sec-0080"> <h5 class="title">Detection bias</h5> <p>When assessing for detection bias, nine studies were found to be at low risk of bias (<a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>). Eight were judged to be at unclear risk of bias (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). Outcome assessors were not blinded in <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>. </p> </section> </section> <section id="CD012839-sec-0081"> <h4 class="title">Incomplete outcome data</h4> <p>In two studies, attrition rates were sufficiently different enough to induce clinically relevant bias in intervention effect estimates (<a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>), and in one study four times more patients from the intervention group withdrew due to non‐compliance compared to the control group (<a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>). These studies were assessed as being at high risk of attrition bias. We found 13 studies to be at low risk of attrition bias as attrition rates were low and balanced across groups (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>), and all participants were accounted for (<a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>). <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a> was found to be at unclear risk of attrition bias. </p> </section> <section id="CD012839-sec-0082"> <h4 class="title">Selective reporting</h4> <p>None of the included studies had a protocol or trial registration with the exception of <a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>. Six studies were judged as being at low risk of bias for reporting all outcomes prespecified in the methods section (<a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>, <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>). Five studies were judged to be at high risk of bias due to a study not reporting on an outcome which was prespecified in the trial protocol (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>), or for reporting outcomes as not statistically significant (or reporting P values) without reporting any further data (<a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>). The rest of the studies were judged to be at unclear risk of bias. </p> </section> <section id="CD012839-sec-0083"> <h4 class="title">Other potential sources of bias</h4> <p>Most of the studies (65%) were judged as being at low risk of bias for other sources of bias as there was no indication of other biases occurring. Five studies were at unclear risk of other bias for not reporting information sufficient to determine whether there were other biases (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>), and one study was judged as being at high risk of bias for including participants with significantly higher CDAI scores in one group (<a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>). </p> </section> </section> <section id="CD012839-sec-0084"> <h3 class="title" id="CD012839-sec-0084">Effects of interventions</h3> <p>See: <a href="./full#CD012839-tbl-0001"><b>Summary of findings for the main comparison</b> Intervention diet compared to control diet for induction of remission in active Crohn's disease</a>; <a href="./full#CD012839-tbl-0002"><b>Summary of findings 2</b> Intervention diet compared to control diet for maintenance of remission in inactive Crohn's disease</a>; <a href="./full#CD012839-tbl-0003"><b>Summary of findings 3</b> Intervention diet compared to control diet for induction of remission in active ulcerative colitis</a>; <a href="./full#CD012839-tbl-0004"><b>Summary of findings 4</b> Intervention diet compared to control diet for maintenance of remission in inactive ulcerative colitis</a> </p> <section id="CD012839-sec-0085"> <h4 class="title">Intervention diet versus control diet for the induction of remission in active CD</h4> <p>Six studies compared various exclusion diets with control diets in participants with active Crohn's disease (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a>; <a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>; <a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a>; <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>). The exclusion diets that were assessed included low refined carbohydrates, low microparticle, low fiber, low calcium, symptoms‐guided and a highly restricted organic diet. </p> <section id="CD012839-sec-0086"> <h5 class="title">Induction of remission</h5> <p>The effect of low refined carbohydrates, low microparticle diet, low calcium diet, symptoms‐guided diet, and a highly restricted organic diet on inducing remission in active CD is uncertain as the certainty of the evidence was assessed as very low (See <a href="./references#CD012839-fig-0004" title="">Analysis 1.1</a>; <a href="./full#CD012839-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>At 4 weeks, remission was achieved by all participants (4/4) in the high fiber, low refined carbohydrates diet group compared with none of the participants (0/3) in the control group (RR 7.20, 95% CI 0.53 to 97.83; 7 participants; 1 study; very low certainty evidence). Forty‐four per cent (23/52) of patients in the low microparticle diet group achieved remission at 16 weeks compared to 25% (13/51) of control‐group patients (RR 3.13, 95% CI 0.22 to 43.84; 103 participants; 2 studies; I² = 73%; very low certainty evidence). Fifty per cent (16/32) of participants in the symptoms‐guided diet group achieved remission (unclear when remission was measured) compared to 0% (0/19) of participants in the control group (RR 20.00, 95% CI 1.27 to 315.40; 51 participants; 1 study; very low certainty evidence). Fifty per cent (4/8) of patients in the highly restricted organic diet group achieved remission at 6 weeks (50%; 4/8) compared to 50% (5/10) of the control group (RR 1.00, 95% CI 0.39 to 2.53; 18 participants; 1 study; very low certainty evidence). Thirty‐seven per cent (16/43) of participants in the low calcium diet group achieved remission at 16 weeks compared to 30% (12/40) of the control group (RR 1.24, 95% CI 0.67 to 2.29; 83 participants; 1 study; very low certainty evidence). </p> </section> <section id="CD012839-sec-0087"> <h5 class="title">Need for surgery</h5> <p>The effect of a low microparticle diet or a low fiber diet on the need for surgery is uncertain (<a href="./references#CD012839-fig-0009" title="">Analysis 1.6</a>). At 4 months, the proportion of patients who needed surgery in the low microparticle group was 10% (1/10) compared to 0% (0/10) in the control group (RR 3.00, 95% CI 0.14 to 65.90; 20 participants ; 1 study). After 24 months, the need for surgery was reported among an equal proportion of patients on both low fiber diet (14%; 5/30) and control diet (14%; 4/28) diet (RR 1.17, 95% CI 0.35 to 3.91; 58 participants; 1 study). </p> </section> <section id="CD012839-sec-0088"> <h5 class="title">Health related quality of life (IBDQ)</h5> <p>It is uncertain whether symptoms‐guided or highly restricted organic diets improve health related quality of life as the certainty of the evidence was assessed as very low (<a href="./references#CD012839-fig-0008" title="">Analysis 1.5</a>; <a href="./full#CD012839-tbl-0001">summary of findings Table for the main comparison</a>). The mean difference in the IBDQ‐score between the symptoms‐guided diets (mean 175.9 +/‐ 28.8; 32 participants) and the control diet (mean 152.15 +/‐ 29.6; 19 participants) (follow‐up period unclear) was 23.75 (95% CI 7.12 to 40.38; 51 participants; 1 study; very low certainty evidence). The mean IBDQ score among the followers of the highly restricted organic diet after 24 weeks was 196 (+/‐ 20) compared to a mean score of 192 (SD = 20) found among the control group (MD 4.00, 95% CI ‐17.86 to 25.86; 14 participants; 1 study; very low certainty evidence). </p> <p>Two studies also reported on IBDQ but did not report sufficient information to allow for meta‐analysis. <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a> measured IBDQ scores among patients in both the low and normal microparticle diet (reported P = 0.2; 83 participants; no specific data for either group reported) and the low versus normal calcium diet (reported P = 0.7; 83 participants; no specific data for either group reported) groups after 52 weeks. However, data were not sufficiently reported for a meta‐analysis. <a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a> reported higher scores on the IBDQ in the intervention group over time than those in control group during the 4‐week period (reported P = 0.028; 7 participants). Change in mean scores were reported in the low refined carbohydrate group (44.25 points) and the control diet (19 points). When both groups were compared, reported P = 'n.s'. </p> </section> <section id="CD012839-sec-0089"> <h5 class="title">Surrogate biomarkers of inflammation</h5> <p>One study with 14 participants and a follow‐up of 24 weeks reported on CRP and ESR. It is uncertain whether highly restricted organic diets lead to a difference in CRP (<a href="./references#CD012839-fig-0005" title="">Analysis 1.2</a>) or ESR (<a href="./references#CD012839-fig-0006" title="">Analysis 1.3</a>). At 24 weeks, the mean CRP among the followers of the highly restricted organic diet was 1.1 mg/dL (+/‐ 1) compared to a mean of 0.7 mg/dL (+/‐ 0.4) in the control group (MD 0.40, 95% CI ‐0.51 to 1.31; 14 participants; 1 study); while the mean ESR was 15 mm/h (+/‐ 3) in the highly restricted organic diet compared to a mean of 20 mm/h (+/‐ 20) found among the control group (MD ‐5.00, 95% CI ‐15.15 to 5.15; 14 participants; 1 study). </p> <p>CRP, ESR and fecal calprotectin data in the low microparticle (42 participants) versus normal microparticle (41 participants) diet (reported P = 0.2, 0.5 and 0.07 respectively) and among the low calcium (43 participants) versus normal (40 participants) calcium diet (reported P = 0.6, 0.6 and 0.9 respectively) at week 52 were reported in <a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a>, however, the data were not shown. </p> <p><a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a> also measured CRP (reported P = 0.125) and ESR (reported P = 0.788) at 4 weeks. No further details were provided. </p> </section> <section id="CD012839-sec-0090"> <h5 class="title">Endoscopic improvement</h5> <p>The effect of highly restricted organic diets on endoscopic improvement is uncertain (<a href="./references#CD012839-fig-0007" title="">Analysis 1.4</a>). At 24 weeks 60% (3/5) of participants in the highly restricted organic diet group reported endoscopic improvement versus 11% (1/9) in the control group (RR 5.40, 95% CI 0.74 to 39.17; 14 participants; 1 study). </p> </section> <section id="CD012839-sec-0091"> <h5 class="title">Disease progression</h5> <p>Disease progression was reported in two studies which compared highly restricted organic diet and low fiber diet with control diets (<a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a>; <a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a>). The effect of highly restricted organic diets and low fiber diet on disease progression is uncertain (<a href="./references#CD012839-fig-0010" title="">Analysis 1.7</a>). At 24 weeks, progression of disease was reported in 20% (1/5) of participants in the highly restricted organic diet compared to 33% (3/9) of participants in the control group (RR 0.60, 95% CI 0.08 to 4.35; 14 participants; 1 study). After 24 months, progression of disease was reported in 37% (11/30) participants in the low fiber diet group versus 28% (8/28) in the control (RR 1.28, 95% CI 0.61 to 2.72; 58 participants; 1 study). </p> </section> </section> <section id="CD012839-sec-0092"> <h4 class="title">Intervention diet versus control diet for the maintenance of remission in inactive CD </h4> <p>Seven studies compared various exclusion diets with control equivalent in inactive CD (<a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a>; <a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a>; <a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>; <a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a>). The exclusion diets studied included low refined carbohydrate diet, symptoms‐guided diet, low red processed meat diet and low disaccharides / grains / saturated fats / red and processed meat diet. </p> <section id="CD012839-sec-0093"> <h5 class="title">Clinical relapse</h5> <p>There is no clear difference in clinical relapse rates when low refined carbohydrate diets, symptoms‐guided diets and low red processed meat diets are compared with control diet. The certainty of the evidence is judged as low (<a href="./references#CD012839-fig-0011" title="">Analysis 2.1</a>; <a href="./full#CD012839-tbl-0002">summary of findings Table 2</a>). </p> <p>At 12 to 24 months, the proportion of participants with clinical relapse in the low refined carbohydrate group was 67% (176/264) compared to 64% (193/303) in the control group (RR 1.04, 95% CI 0.87 to 1.25; 567 participants; 3 studies; I² = 35%; low certainty evidence). In the symptoms guided diet clinical relapse was reported in 48% (24/50) of participants compared to 83% (40/48) of participants in the control diet at 6 to 24 months (RR 0.53, 95% CI 0.28 to 1.01; 98 participants; 2 studies; I² = 54%; low certainty evidence). At 48 weeks, 66% (63/96) of participants in the low red processed meat diet group relapsed compared to 63% (75/118) in the control group (RR 1.03, 95% CI 0.85 to 1.26; 214 participants; 1 study; I² = 0%; low certainty evidence). At 12 months, an exclusion diet of low disaccharides / grains / saturated fats / red and processed meat resulted in no clinical relapse (0/16) compared to 26% (10/38) among the control group (RR 0.11, 95% CI 0.01 to 1.76; 54 participants; 1 study; very low certainty evidence). </p> <p>We carried out sensitivity analyses based on per‐protocol data and fixed‐effect model. In both instances we found that the effect of symptoms‐guided diets on clinical relapse was uncertain. </p> </section> <section id="CD012839-sec-0094"> <h5 class="title">Need for surgery</h5> <p>It is uncertain whether low refined carbohydrate diets reduce the need for surgery (<a href="./references#CD012839-fig-0014" title="">Analysis 2.4</a>). After 24 months, surgery appeared to be necessary for 4% (8/200) of the participants following a low refined carbohydrate diet compared to 9% (16/172) of control group participants (RR 0.44, 95% CI 0.19 to 1.00; 372 participants; 2 studies; I² = 0%). </p> </section> <section id="CD012839-sec-0095"> <h5 class="title">Escalation of therapy</h5> <p><a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a> reported on escalation of therapy and it is uncertain whether low refined carbohydrate diet reduces the incidence of escalation of therapy (<a href="./references#CD012839-fig-0016" title="">Analysis 2.6</a>). Escalation of therapy was reported for 10% (1/10) of the participants in the low refined carbohydrate group compared to none (0/10) in the control group (RR 3.00, 95% CI 0.14 to 65.90; 20 participants; 1 study). </p> </section> <section id="CD012839-sec-0096"> <h5 class="title">Withdrawals due to adverse events</h5> <p>Withdrawals due to adverse events were reported in one study with 78 participants during 24 months of follow‐up. We are uncertain whether symptoms‐guided diets reduce withdrawals due to adverse events (<a href="./references#CD012839-fig-0017" title="">Analysis 2.7</a>). None (0/40) of the participants in the symptoms‐guided diet group withdrew from the study due to adverse events compared to 5% (2/38) of the participants from the control diet (RR 0.19, 95% CI 0.01 to 3.84; 74 participants; 1 study). Both of the patients in the control group were withdrawn due to steroid side effects. </p> </section> <section id="CD012839-sec-0097"> <h5 class="title">Surrogate markers of inflammation</h5> <p><a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a> assessed the effect of symptoms‐guided diets on CRP ( <a href="./references#CD012839-fig-0012" title="">Analysis 2.2</a>). After 24 months, participants in the symptoms‐based diets had mean CRP scores of 2.71 mg/dL (+/‐ 6.58) compared to 2.42 mg/dL (+/‐ 2.9) in the control group (MD 0.29, 95% CI ‐1.95 to 2.53; 78 participants; 1 study). </p> <p>Evidence from two studies shows that the effect of symptoms‐guided diets on ESR is uncertain (<a href="./references#CD012839-fig-0013" title="">Analysis 2.3</a>). The mean ESR value during a follow‐up of 6 to 24 months, was 27.6 (SD = 24.7) mm/h among the symptoms‐guided diet followers and 33.2 (SD = 26.6) mm/h in the control diet group (MD ‐7.29, 95% CI ‐17.22 to 2.64; I² = 0%; 95 participants; 2 studies; low certainty evidence). </p> <p><a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a> indicated that participants in the intervention group had improved CRP concentrations. No further details were provided. </p> </section> <section id="CD012839-sec-0098"> <h5 class="title">Disease progression</h5> <p>It is uncertain whether low refined carbohydrate diets reduce disease progression (<a href="./references#CD012839-fig-0015" title="">Analysis 2.5</a>). At the end of the 24‐month follow‐up period, disease progression was reported in 20% (1/5) of the participants on low refined carbohydrate compared to 17% (1/6) on the control diet (RR 1.20, 95% CI 0.10 to 14.69; 11 participants; 1 study). </p> </section> </section> <section id="CD012839-sec-0099"> <h4 class="title">Intervention diet versus control diet for the induction of remission in active UC</h4> <p>One study assessed a symptoms‐guided diet in participants with active UC (<a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a>). </p> <section id="CD012839-sec-0100"> <h5 class="title">Induction of remission</h5> <p>It is uncertain whether symptoms‐guided diets improve the induction of remission as the certainty of the evidence has been assessed as very low (<a href="./references#CD012839-fig-0018" title="">Analysis 3.1</a>; <a href="./full#CD012839-tbl-0003">summary of findings Table 3</a>). After six weeks, symptoms‐guided diet led to induction of remission among 36% ( 4/11) of symptoms‐guided diet participants compared to none (0/10) of the participants in the control dietary arm (RR 8.25, 95% CI 0.50 to 136.33; 21 participants; 1 study; very low certainty evidence). </p> </section> <section id="CD012839-sec-0101"> <h5 class="title">Clinical improvement</h5> <p>It is uncertain whether symptoms‐guided diets lead to clinical improvement (<a href="./references#CD012839-fig-0019" title="">Analysis 3.2</a>). After six weeks of symptoms‐guided diets, 45% (5/11) of participants achieved clinical improvement versus 10% (1/10) in the control group (RR 4.55, 95% CI 0.63 to 32.56; 21 participants; 1 study). </p> </section> <section id="CD012839-sec-0102"> <h5 class="title">Endoscopic improvement</h5> <p>Whether symptoms‐guided diets lead to endoscopic improvement remains uncertain (<a href="./references#CD012839-fig-0020" title="">Analysis 3.3</a>). At 6 weeks, endoscopic improvement was achieved by 45% (5/11) of patients on a symptoms‐guided diet compared to 10% (1/10) of the control group (RR 3.64, 95% CI 1.00 to 13.23; 21 participants; 1 study). </p> </section> <section id="CD012839-sec-0103"> <h5 class="title">Histologic improvement</h5> <p>The impact of symptoms‐guided diets on histologic improvement is uncertain (<a href="./references#CD012839-fig-0021" title="">Analysis 3.4</a>). At 6 weeks, 27% (3/11) of participants in the symptoms‐guided diet group improved histologically compared to 30% (3/10) of the control group (RR 0.91, 95% CI 0.24 to 3.51; 21 participants; 1 study). </p> </section> </section> <section id="CD012839-sec-0104"> <h4 class="title">Intervention diet versus control diet for the maintenance of remission in inactive UC </h4> <p>Four studies compared various exclusion diets with control diets in participants with inactive UC (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>; <a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>; <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). The exclusion diets studied included the Alberta‐based anti‐inflammatory diet (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>), a Carrageenan‐free diet (<a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a>), and a milk‐free diet (<a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>; <a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a>). </p> <section id="CD012839-sec-0105"> <h5 class="title">Clinical relapse</h5> <p>All four studies reported on clinical relapse, but it is uncertain whether the Alberta‐based anti‐inflammatory diet, the Carrageenan‐free diet or the milk free diet reduces clinical relapse, as the certainty of the evidence was assessed as very low or low (<a href="./references#CD012839-fig-0022" title="">Analysis 4.1</a>; <a href="./full#CD012839-tbl-0004">summary of findings Table 4</a>). At 6 months, the Alberta‐based anti‐inflammatory diet led to clinical relapse in 36% (5/14) of patients in comparison to 29% (4/14) of control participants (RR 1.25, 95% CI 0.42 to 3.70; 28 participants; 1 study; very low certainty evidence). Thirty per cent (3/10) of patients following the carrageenan‐free diet for 12 months reported clinical relapse compared to 60% (3/5) of the control group participants (RR 0.50, 95% CI 0.15 to 1.64; 15 participants; 1 study; very low certainty evidence). At 12 months, 59% (23/39) of milk free diet participants relapsed compared to 68% (26/38) of control diet participants (RR 0.83, 95% CI 0.60 to 1.15; 77 participants; 2 studies; I² = 0%; low certainty evidence). </p> <p><b>Endoscopic relapse</b> </p> <p>Mean endoscopic Matt colonoscopy grading scores (0 to 4; higher score = increased severity; <a href="./references#CD012839-bbs2-0100" title="MattsSF . The value of rectal biopsy in the diagnosis of ulcerative colitis. QJM1961;30:393‐407. ">Matt 1961</a>) were reported by in <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a> (mean change score: reported P = 0.5; 29 participants) after 12 months for the milk ‐free diet and control diet, however, data were not sufficient for a statistical analysis. </p> <p><b>Histologic relapse</b> </p> <p>Mean histologic Matt scores at 12 months were reported in <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a> (mean change score: reported P = 0.4; 29 participants) for the milk ‐free and control dietary arms, however, data were not sufficiently reported for a statistical analysis. </p> </section> <section id="CD012839-sec-0106"> <h5 class="title">Surrogate inflammatory biomarkers</h5> <p>One study with 12 participants (<a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a>), reported on fecal calprotectin (<a href="./references#CD012839-fig-0023" title="">Analysis 4.2</a>), IL‐6 (<a href="./references#CD012839-fig-0025" title="">Analysis 4.4</a>), IL‐8 (<a href="./references#CD012839-fig-0026" title="">Analysis 4.5</a>) and TNF‐α (<a href="./references#CD012839-fig-0024" title="">Analysis 4.3</a>) and it is uncertain whether carrageenan‐free diets improve these parameters. At 12 months, the mean difference in the levels of these parameters between the carrageenan and the control group were as follows: fecal calprotectin 60.00 g/gm (95% CI ‐59.24 to 179.24); IL‐6 1.94 pg/ml (95% CI ‐0.35 to 4.23); IL‐8 38.00 pg/ml (95% CI ‐139.24 to 215.24) and TNF‐α ‐4.50 pg/ml (95% CI ‐8.92 to ‐0.08). After 12 months, median and range of CRP (reported P = 0.6), ESR (reported P = 0.3) and FC (reported P = 0.3) were reported in <a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a>, however, as measures of variance were not reported, we were unable to analyse the results further. </p> </section> <section id="CD012839-sec-0107"> <h5 class="title">Health related quality of life (SIBDQ)</h5> <p>It is uncertain whether carrageenan‐free diets improve health related quality of life as the certainty of the evidence has been assessed as very low (<a href="./references#CD012839-fig-0027" title="">Analysis 4.6</a>).The mean difference in the SIBDQ between the carrageenan group and the non‐carrageenan group at 12 months was ‐1.70 (95% CI ‐8.23 to 4.83; 12 participants; 1 study; very low certainty evidence). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012839-sec-0108" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012839-sec-0108">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012839-sec-0163">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012839-sec-0108"></div> <section id="CD012839-sec-0109"> <h3 class="title" id="CD012839-sec-0109">Summary of main results</h3> <p>We included 18 randomized controlled trials (1878 randomized participants) that assessed dietary interventions for the induction and maintenance of remission in IBD. The trials were subdivided into groups based on disease state and type: active CD, inactive CD, active UC and inactive UC. The dietary interventions studied involved some dietary restriction or exclusion of single or multiple food components which are believed to trigger IBD symptoms or inflammation. The diets were so varied that there was little scope for pooling data. </p> <section id="CD012839-sec-0110"> <h4 class="title">Induction and maintenance of remission in Crohn's disease</h4> <p>There is insufficient evidence to determine whether exclusion diets (low refined carbohydrates, low microparticle, symptoms‐guided diet, highly restricted organic diet and low calcium diet) improve clinical remission rates in active Crohn's disease as the certainty of the evidence was assessed as very low. </p> <p>When we looked at the evidence for inactive Crohn's disease, there was little or no difference in clinical relapse rates when exclusion diets (low refined carbohydrates, symptoms‐guided and low red/processed meat diet) were compared with control diets. The certainty of the evidence was low due to risk of bias and imprecision. On the other hand, we found insufficient evidence to determine whether low disaccharides/low grain/low saturated fats/low red and processed meat diet reduces clinical relapse as the certainty of evidence was assessed as very low. </p> <p>Other than two participants being withdrawn for steroid‐related side effects in a small maintenance of remission study (<a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>), none of the studies assessing diet in CD reported on adverse events. </p> </section> <section id="CD012839-sec-0111"> <h4 class="title">Induction and maintenance of remission in ulcerative colitis</h4> <p>There was insufficient evidence on whether symptoms‐based diets improve clinical remission rates in active ulcerative colitis (very low certainty). </p> <p>We found very low certainty evidence from two trials which was insufficient to determine whether the Alberta‐based anti‐inflammatory diet, or a Carrageenan‐free diet reduce clinical relapse rates in inactive ulcerative colitis. We found low certainty evidence from two studies which was insufficient to determine if a milk‐free diet reduces clinical relapse rates in inactive ulcerative colitis. </p> <p>None of the studies assessing diets in UC reported on adverse events.</p> </section> </section> <section id="CD012839-sec-0112"> <h3 class="title" id="CD012839-sec-0112">Overall completeness and applicability of evidence</h3> <p>The evidence was very limited due to the initial clinical design, specific interventions and choice of populations. In particular, several studies do not describe in much detail the actual dietary manipulations used. As this almost excludes any form of true dissemination and replication, the applicability is severely hampered. Examples include high fiber + reduced refined carbohydrate, low carbohydrate + high protein and fat, milk‐free + low‐roughage, low disaccharides + low grains + low saturated fats + low red and low processed meat. This is further exemplified in the results of one intervention which showed a potential efficacious outcome in the context of symptoms‐guided diet. As this is a very subjective dietary therapy and no national or international consensus or evidence‐based method, framework or evidence was cited in the individual studies, further local research or practice in this area is also severely hampered. All the studies in this review except one, are based on an adult population with little or no information on severity of disease. </p> <p>It is a real concern that no adverse events related to the interventions were discussed in any of the studies. Patients who access information from different media which promote dietary interventions based on these studies and try these diets, need to be informed of any adverse effects yet this vital piece of information is absent. </p> </section> <section id="CD012839-sec-0113"> <h3 class="title" id="CD012839-sec-0113">Quality of the evidence</h3> <p>The included studies lacked homogeneity of any sort and were methodologically flawed resulting in very heterogenous data that were difficult to analyse or summarise. This resulted in our downgrading the evidence to low or very low certainty. Another contributing factor was the lack of information to assess risk of bias and high risk of bias resulting from the difficulty in blinding participants and personnel to dietary interventions. Most of the studies had small sample sizes and sparse data with the smallest study having as few as seven participants. We found that having inadequately powered heterogenous studies with limited scope for pooling, resulted in mostly imprecise results. </p> <p>There was no indirectness as the included studies were all within the scope of the review. Having a limited number of studies precluded our assessment of publication bias. </p> </section> <section id="CD012839-sec-0114"> <h3 class="title" id="CD012839-sec-0114">Potential biases in the review process</h3> <p>We acknowledge that there are certain decisions which were made during the review process which may have introduced bias in the results. For instance, some studies reported results which we had to estimate visually from graphs. Using this method may have led to inaccuracies; however, having counter measures, such as extracting the data in duplicate coupled with additional checking from other members of the author team, is likely to have minimised error. Again, the differences in dietary interventions may have led to the misclassification of diets resulting in erroneous pooling of clinically heterogenous study data. This has been a consequence of the plurality, lack of consensus and insufficient reporting of trial interventions among study investigators. These obvious differences in interventions and controls highlighted meant that we rarely downgraded evidence for unexplained heterogeneity (inconsistency). However, as most of the evidence was of very low certainty and obtained from single trials, this may not be a source of concern as a further downgrade of the certainty of evidence would not change the interpretation of the results. </p> </section> <section id="CD012839-sec-0115"> <h3 class="title" id="CD012839-sec-0115">Agreements and disagreements with other studies or reviews</h3> <p>Although it was recommended in the NICE guideline that people with Crohn's disease be given information on diet and nutrition, no details were provided on what the diets should be (<a href="./references#CD012839-bbs2-0104" title="National Institute for Health and Care Excellence (2014). Crohn's disease: management. NICE guideline (CG183). ">NICE 2016</a>). There is also no indication that this recommendation is based on systematic review evidence. There are currently no other systematic reviews assessing dietary interventions for induction and maintenance of remission in IBD. Compared to other studies, it is important to note that RCTs which have evaluated symptoms‐guided diets in active and inactive CD (<a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a>; <a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a>; <a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a>), when analyzed individually, all show that the diet offers an advantage for the induction and maintenance of remission in CD. However, the evidence from our review was insufficient to support the use of symptoms‐guided diets. This could be an area for future research as more studies are needed. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012839-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Source: Mullin 2016." data-id="CD012839-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Source: <a href="./references#CD012839-bbs2-0102" title="MullinGE . Role of diet in Inflammatory Bowel Disease. Presented at: Digestive Disease Week; May 2016; San Diego, CA. ">Mullin 2016</a>. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012839-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012839-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 1 Induction of remission." data-id="CD012839-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 1 Induction of remission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 2 Surrogate inflammatory biomarker ‐ CRP." data-id="CD012839-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 2 Surrogate inflammatory biomarker ‐ CRP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 3 Surrogate inflammatory biomarker ‐ ESR." data-id="CD012839-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 3 Surrogate inflammatory biomarker ‐ ESR. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 4 Endoscopic improvement." data-id="CD012839-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 4 Endoscopic improvement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 5 Health related quality of life ‐ IBDQ." data-id="CD012839-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 5 Health related quality of life ‐ IBDQ. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 6 Need for surgery." data-id="CD012839-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 6 Need for surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 7 Disease progression." data-id="CD012839-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Intervention diet versus control diet in active Crohn's disease, Outcome 7 Disease progression. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 1 Clinical relapse." data-id="CD012839-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 1 Clinical relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 2 Surrogate inflammatory biomarker ‐ CRP." data-id="CD012839-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 2 Surrogate inflammatory biomarker ‐ CRP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 3 Surrogate inflammatory biomarker ‐ ESR." data-id="CD012839-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 3 Surrogate inflammatory biomarker ‐ ESR. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 4 Need for surgery." data-id="CD012839-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 4 Need for surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 5 Disease progression." data-id="CD012839-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 5 Disease progression. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 6 Escalation of therapy." data-id="CD012839-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 6 Escalation of therapy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 7 Withdrawals due to adverse events." data-id="CD012839-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Intervention diet versus control diet in inactive Crohn's disease, Outcome 7 Withdrawals due to adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Intervention diet versus control diet in active ulcerative colitis, Outcome 1 Induction of remission." data-id="CD012839-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Intervention diet versus control diet in active ulcerative colitis, Outcome 1 Induction of remission. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Intervention diet versus control diet in active ulcerative colitis, Outcome 2 Clinical improvement." data-id="CD012839-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Intervention diet versus control diet in active ulcerative colitis, Outcome 2 Clinical improvement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Intervention diet versus control diet in active ulcerative colitis, Outcome 3 Endoscopic improvement." data-id="CD012839-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Intervention diet versus control diet in active ulcerative colitis, Outcome 3 Endoscopic improvement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Intervention diet versus control diet in active ulcerative colitis, Outcome 4 Histologic improvement." data-id="CD012839-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Intervention diet versus control diet in active ulcerative colitis, Outcome 4 Histologic improvement. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 1 Clinical relapse." data-id="CD012839-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 1 Clinical relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 2 Fecal calprotectin." data-id="CD012839-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 2 Fecal calprotectin. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 3 Surrogate inflammatory biomarker ‐ TNF‐α." data-id="CD012839-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 3 Surrogate inflammatory biomarker ‐ TNF‐α. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 4 Surrogate inflammatory biomarker ‐ IL‐6." data-id="CD012839-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 4 Surrogate inflammatory biomarker ‐ IL‐6. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 5 Surrogate inflammatory biomarker ‐ IL‐8." data-id="CD012839-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 5 Surrogate inflammatory biomarker ‐ IL‐8. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012839-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/urn:x-wiley:14651858:media:CD012839:CD012839-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_t/tCD012839-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 6 Health related quality of life ‐ SIBDQ." data-id="CD012839-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Intervention diet versus control diet in inactive ulcerative colitis, Outcome 6 Health related quality of life ‐ SIBDQ. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/media/CDSR/CD012839/image_n/nCD012839-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012839-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intervention diet compared to control diet for induction of remission in active Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intervention diet compared to control diet in active Crohn's disease for induction of remission in active Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with active Crohn's disease<br/> <b>Setting:</b> home<br/> <b>Intervention:</b> intervention diet (various)<br/> <b>Comparison:</b> control diet (various) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control diet</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intervention diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission at 4 weeks ‐ High‐fiber, low refined carbohydrates diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 7.20<br/> (0.53 to 97.83) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>7 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We were unable to calculate absolute effects. Remission was induced in 100% (4/4) of participants in the low refined carbohydrates diet group compared to 0% (0/3) in the control group </p> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission at 16 weeks ‐ Low microparticle diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 3.13<br/> (0.22 to 43.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>103 (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>255 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>798 per 1,000<br/> (56 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission at 16 weeks ‐ Low calcium diet</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.24</p> <p>(0.67 to 2.29)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>83 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,4</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>372 per 1000 (201 to 687)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission (timeframe not reported) ‐ Symptoms‐guided diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 20.00<br/> (1.27 to 315.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>51 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We were unable to calculate absolute effects. Remission was induced in 50% (16/32) of participants in the symptoms‐guided diet group compared to 0% (0/19) in the control </p> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission at 6 weeks ‐ Highly restricted, organic diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/> (0.39 to 2.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>18 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical remission was defined as CDAI ≤150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>500 per 1,000<br/> (195 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life (timeframe not reported) ‐ IBDQ ‐ Symptoms‐guided diet</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean health related quality of life ‐ IBDQ ‐ was 0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 23.75 higher</p> <p>(7.12 higher to 40.38 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>51 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,7</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health‐related quality of life at 6 weeks ‐ IBDQ ‐ Highly restricted, organic diet</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>The mean health related quality of life ‐ IBDQ was 0</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>MD 4 higher</p> <p>(17.86 lower to 25.86 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,8</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>None reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR</b> : risk ratio; <b>CDAI:</b> Crohn's disease activity index; <b>IBDQ:</b> Inflammatory Bowel Disease Questionnaire; <b>MD:</b> Mean difference. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high or unclear risk of bias </p> <p><sup>2</sup> Downgraded two levels due to serious imprecision (4 events) </p> <p><sup>3</sup> Downgraded two levels due to serious imprecision (36 events) </p> <p><sup>4</sup> Downgraded two levels due to serious imprecision (28 events) </p> <p><sup>5</sup> Downgraded two levels due to serious imprecision (16 events) </p> <p><sup>6</sup> Downgraded two levels due to serious imprecision (9 events) </p> <p><sup>7</sup> Downgraded one level due to imprecision (51 participants) </p> <p><sup>8</sup> Downgraded two levels due to serious imprecision (14 participants) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Intervention diet compared to control diet for induction of remission in active Crohn's disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012839-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intervention diet compared to control diet for maintenance of remission in inactive Crohn's disease</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intervention diet compared to control diet for maintenance of remission in inactive Crohn's disease</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with inactive Crohn's disease<br/> <b>Setting:</b> home<br/> <b>Intervention:</b> intervention diet (various)<br/> <b>Comparison:</b> control diet (various) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control diet</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intervention diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 12 to 24 months ‐ Low refined carbohydrate diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.04<br/> (0.87 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>567 (3 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined as CDAI &gt; 150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>637 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>662 per 1,000<br/> (554 to 796) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 6 to 24 months ‐ Symptoms‐guided diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.53<br/> (0.28 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>98 (2 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined as CDAI &gt; 150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>833 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>442 per 1,000<br/> (233 to 842) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 48 weeks ‐ Low red, processed meat diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.03<br/> (0.85 to 1.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>214 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined as CDAI &gt; 150</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>636 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>655 per 1,000<br/> (540 to 801) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 12 months ‐ Exclusion diets (low disaccharides, grains, saturated fats, red and processed meats) </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.11<br/> (0.01 to 1.76) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>54 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>29 per 1,000<br/> (3 to 463) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health‐related quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>None reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>None reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>CDAI:</b> Crohn's disease activity index. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high or unclear risk of bias </p> <p><sup>2</sup> Downgraded one level due to imprecision (369 events) </p> <p><sup>3</sup> Downgraded one level due to imprecision (64 events) </p> <p><sup>4</sup> Downgraded one level due to imprecision (138 events) </p> <p><sup>5</sup> Downgraded two levels due to serious imprecision (10 events) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intervention diet compared to control diet for maintenance of remission in inactive Crohn's disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012839-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Intervention diet compared to control diet for induction of remission in active ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intervention diet compared to control diet for the induction of remission in active ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population: p</b> eople with active ulcerative colitis<br/> <b>Setting:</b> home<br/> <b>Intervention:</b> intervention diet (various)<br/> <b>Comparison:</b> control diet (various) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control diet</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intervention diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Induction of remission ‐ Symptoms‐guided diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 8.25<br/> (0.50 to 136.33) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>21 (1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>We were unable to calculate absolute effects. Remission was induced in 36% (4/11) of symptoms‐guided diet participants compared to 0% (0/10) of the control group </p> <p>Remission was defined as passage of normal stools with absence of rectal bleeding</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1,000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Health‐related quality of life</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high or unclear risk of bias </p> <p><sup>2</sup> Downgraded two levels due to serious imprecision (4 events) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Intervention diet compared to control diet for induction of remission in active ulcerative colitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012839-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Intervention diet compared to control diet for maintenance of remission in inactive ulcerative colitis</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Intervention diet compared to control diet for maintenance of remission in inactive ulcerative colitis</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> Participants with inactive ulcerative colitis<br/> <b>Setting:</b> home<br/> <b>Intervention:</b> Intervention diet (various)<br/> <b>Comparison:</b> control diet (various) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with control diet in inactive ulcerative colitis</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Intervention diet</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 6 months ‐ Anti‐inflammatory diet (Alberta‐based)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/> (0.42 to 3.70) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>28<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined by a Mayo score &gt; 3</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>286 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>357 per 1,000<br/> (120 to 1,000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 12 months ‐ Carrageenan‐free diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/> (0.15 to 1.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>15<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined by an increase in the Simple Clinical Colitis Activity Index of &gt; 2 points </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>600 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>300 per 1,000<br/> (90 to 984) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Clinical relapse at 12 months ‐ Milk free diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.83<br/> (0.60 to 1.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>77<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW<sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Relapse was defined by a Pediatric Ulcerative Colitis Activity Index score &gt; 10 points or by clinical symptoms (4 or more diarrhea movements per day with visible blood) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>684 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>568 per 1,000<br/> (411 to 787) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health related quality of life at 12 months ‐ SIBDQ ‐ Carrageenan‐free diet</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean health related quality of life ‐ SIBDQ was 0</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 1.7 higher<br/> (4.83 lower to 8.23 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW<sup>1,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign=""> <p>Not reported in any of the studies</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>SIBDQ:</b> Short Inflammatory Bowel Disease Questionnaire; <b>MD:</b> Mean difference </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded one level due to high or unclear risk of bias </p> <p><sup>2</sup> Downgraded two levels due to serious imprecision (9 events) </p> <p><sup>3</sup> Downgraded two levels due to serious imprecision (6 events) </p> <p><sup>4</sup> Downgraded one level due to imprecision (49 events) </p> <p><sup>5</sup> Downgraded two levels due to very serious imprecision (12 participants) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Intervention diet compared to control diet for maintenance of remission in inactive ulcerative colitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012839-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Dietary components can influence risk of inflammatory bowel disease</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Dietary Component</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Effect on IBD Risk</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>References</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Animal Protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0093" title="JantchouP , MoroisS , Clavel‐ChapelonF , Boutron‐RuaultMC , CarbonnelF . Animal protein intake and risk of Inflammatory Bowel Disease: the E3N prospective study. American Journal of Gastroenterology2010;105(10):2195‐201. ">Jantchou 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Heme iron, sulfur</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0066" title="AnanthakrishnanAN , KhaliliH , SongM , HiguchiLM , RichterJM , NimptschK , et al. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflammatory Bowel Diseases2015;21:2311‐9. ">Ananthakrishnan 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Refined sugars</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0092" title="JarnerotG , JarnmarkI , NilssonK . Consumption of refined sugar by patients with Crohn’s disease, ulcerative colitis, or irritable bowel syndrome. Scandinavian Journal of Gastroenterology1983;18(8):999‐1002. ">Janerot 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High trans‐fat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0065" title="AnanthakrishnanAN , KhaliliH , KonijetiGG , HiguchiLM , deSilvaP , FuchsCS , et al. Long‐term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut2014;63:776‐84. ">Ananthakrishnan 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fiber</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0066" title="AnanthakrishnanAN , KhaliliH , SongM , HiguchiLM , RichterJM , NimptschK , et al. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflammatory Bowel Diseases2015;21:2311‐9. ">Ananthakrishnan 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fruit</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0090" title="HouJK , AbrahamB , El‐SeragH . Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. American Journal of Gastroenterology2011;106:563‐73. ">Hou 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vegetables</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0090" title="HouJK , AbrahamB , El‐SeragH . Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. American Journal of Gastroenterology2011;106:563‐73. ">Hou 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High omega‐3 fatty acids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Decreased</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0071" title="ChanSS , LubenR , OlsenA , TjonnelandA , KaaksR , LindgrenS , et al. Association between high dietary intake of the n‐3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease. Alimentary Pharmacology and Therapeutics2014;39(8):834‐42. ">Chan 2014</a> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>Adpated from <a href="./references#CD012839-bbs2-0102" title="MullinGE . Role of diet in Inflammatory Bowel Disease. Presented at: Digestive Disease Week; May 2016; San Diego, CA. ">Mullin 2016</a>. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Dietary components can influence risk of inflammatory bowel disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012839-tbl-0006"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of interventions and outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group 1 (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group 2 (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group 3 (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Group 4 (n)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Remission</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Induction of Remission in Crohn's Disease</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0002" title="BartelG , WeissI , TuretschekK , SchimaW , PüspökA , WaldhoerT , et al. Ingested matter affects intestinal lesions in Crohn's disease. Inflammatory Bowel Diseases2008;14(3):374‐82. [PUBMED: 17932967] ">Bartel 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Restricted organic diet (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low‐fat, high‐carbohydrate, low‐fiber, no red meat diet (9)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4/5 vs. 7/9 (week 6)</p> <p>PP:4/5 vs. 5/9 (week 24)</p> <p>ITT: 4/8 vs. 5/10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0005" title="BrothertonCS , TaylorAG , BourguignonC , AndersonJG . A high‐fiber diet may improve bowel function and health‐related quality of life in patients with Crohn disease. Gastroenterology Nursing2014;37(3):206‐16. [PUBMED: 24871666] ">Brotherton 2014</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High‐fiber, reduced refined carbohydrate diet (4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low‐fiber diet (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Remission: 4/4 vs. 0/3 (week 4)</p> <p>Change in pHBI: 5.8 to 0.5 vs. 5.2 to 3.5 (<i>P</i> = 0.008) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0007" title="DarielI , LeviZ , FraserA , HadadB , NivY , FraserG . Elimination diets in the treatment of mildly active Crohn's disease ‐ results of a randomized controlled trial. Gastroenterology2207;132(4):A506‐7. ">Dariel 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sequential elimination diets for 30 food components (32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Conventional nutritional advice (19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response: 16/32 vs. 1/19</p> <p>Remission: 16/32 vs. 0/19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0010" title="LevensteinS , PranteraC , LuziC , D'UbaldiA . Low residue or normal diet in Crohn's disease: a prospective controlled study in Italian patients. Gut1985;26(10):989‐93. [PUBMED: 2996991] ">Levenstein 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low fiber diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal diet (with gradual fiber introduction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0011" title="LomerMC , HarveyRS , EvansSM , ThompsonRP , PowellJJ . Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2001;13(2):101‐6. [PUBMED: 11246607] ">Lomer 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diet low in microparticles. Fibrous fruit and vegetables were excluded (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Foods containing dietary microparticles were not discouraged. Fibrous fruit and vegetables were excluded (10) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PP: 7/9 vs. 0/9 (month 4)</p> <p>ITT: 7/10 vs. 0/10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0012" title="LomerMC , GraingerSL , EdeR , CatterallAP , GreenfieldSM , CowanRE , et al. Lack of efficacy of a reduced microparticle diet in a multi‐centred trial of patients with active Crohn's disease. European Journal of Gastroenterology &amp; Hepatology2005;17(3):377‐84. [PUBMED: 15716665] ">Lomer 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low calcium and low microparticle diet (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low calcium and normal microparticle diet (21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal calcium and low microparticle diet (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normal calcium and normal microparticle diet (20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low vs. normal microparticle groups.</p> <p>Response: 16/42 vs. 17/41 (week 16)</p> <p>Remission: 16/42 vs. 13/41 (week 16)</p> <p>Low versus normal calcium</p> <p>Remission:</p> <p>16/43 versus 13/40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Maintenance of Remission in Crohn's Disease</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0001" title="AlbenbergL , BrensingerC , WuQ , GilroyE , KappelmanM , SandlerR , et al. A diet low in red and processed meats does not reduce the rate of Crohn's disease flares in a randomized controlled trial: results of the food and Crohn's disease exacerbation study (FACES). Gastroenterology2018;154(1):S3. ">Albenberg 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low red and processed meats (96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate red and processed meats (118)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54/87 vs. 72/115 (week 48)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0004" title="BrandesJW , Lorenz‐MeyerH . Sugar free diet: a new perspective in the treatment of Crohn disease? Randomized, control study. Zeitschrift fur Gastroenterologie1981;19(1):1‐12. [PUBMED: 7013307] ">Brandes 1981</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low carbohydrate diet with increased intake of protein and fat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High carbohydrate diet with reduced intake of protein and fat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1/5 vs. 1/6</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0008" title="JonesVA , DickinsonRJ , WorkmanE , WilsonAJ , FreemanAH , HunterJO . Crohn's disease: maintenance of remission by diet. Lancet1985;2(8448):177‐80. [PUBMED: 2862371] ">Jones 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exclusion of foods that provoked symptoms (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unrefined carbohydrate fiber‐rich diet (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3/10 vs. 10/10 (month 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0013" title="Lorenz‐MeyerH , BauerP , NicolayC , SchulzB , PurrmannJ , FleigWE , et al. Omega‐3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scandinavian Journal of Gastroenterology1996;31(8):778‐85. [PUBMED: 8858747] ">Lorenz‐Meyer 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low‐carbohydrate diet of less than 84 g/day (69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Omega‐3 fatty acid capsules and general nutrition guidelines (70)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo and general nutrition guidelines (65)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45/69 vs. 50/70 vs. 46/65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0014" title="MutluE , MikolaitisS , SedghiS , ChakradeoPS , EngenP , ChlipalaG , et al. Dietary treatment of Crohn's disease: a randomized, placebo‐controlled, double‐blinded clinical trial. Gastroenterology2016;150(4):S778. ">Mutlu 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Anti‐IBD diet and placebo supplement (16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fructooligosaccharide supplement and "placebo diet" (19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>"Placebo diet" and placebo supplement (19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0/16 vs. 6/19 vs. 4/19 (month 12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0015" title="RiordanAM , HunterJO , CowanRE , CramptonJR , DavidsonAR , DickinsonRJ , et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet1993;342(8880):1131‐4. [PUBMED: 7901473] ">Riordan 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Elemental diet followed by reintroduction of single food each day and exclusion of symptom‐provoking foods (40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>General dietary advice and prednisolone taper (38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PP: 12/40 vs. 25/38 (month 24)</p> <p>ITT: 21/40 vs. 30/38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0016" title="RitchieJK , WadsworthJ , Lennard‐JonesJE , RogersE . Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. British Medical Journal Clinical Research Edition1987;295(6597):517‐20. [PUBMED: 2822203] ">Ritchie 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unrefined, fiber‐rich diet (190)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Refined carbohydrate‐rich diet and unrestricted sugar intake (162)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>130/190 vs. 96/162 (month 24)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Induction of Remission in Ulcerative Colitis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0006" title="CandyS , BorokG , WrightJP , BonifaceV , GoodmanR . The value of an elimination diet in the management of patients with ulcerative colitis. South African Medical Journal1995;85(11):1176‐9. [PUBMED: 8597010] ">Candy 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Systematic exclusion of symptoms‐provoking foods (11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual diet (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response: 9/11 vs. 1/7 (week 6)</p> <p>Remission: 4/11 vs. 0/7 (week 6)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Maintenance of Remission in Ulcerative Colitis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0003" title="BhattacharyyaS , ShumardT , XieH , DoddaA , VaradyKA , FefermanL , et al. A randomized trial of the effects of the no‐carrageenan diet on ulcerative colitis disease activity. Nutrition and Healthy Aging2017;4:181–192. ">Bhattacharyya 2017</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Carrageenan‐free diet + placebo (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Carrageenan‐free diet + carrageenan‐containing capsules (5)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>PP: 0/7 vs. 3/5 (month 12)</p> <p>ITT: 3/10 vs. 3/5</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0009" title='KeshteliAH , ValchevaR , NickurakC , HalloranBP , vanZantenSV , KroekerK , et al. Adherence to an "Anti‐Inflammatory Diet" for 6 months can decrease fecal calprotectin in ulcerative colitis patients: preliminary findings of a randomized controlled trial. Gastroenterology2016;150(4):S807‐8. '>Keshteli 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alberta‐based Anti‐inflammatory Diet (14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diet based on Canada's Food Guide (14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/14 vs. 4/14 (month 6)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0017" title="StrisciuglioC , GiannettiE , MartinelliM , SciorioE , StaianoA , MieleE . Does cow's milk protein elimination diet have a role on induction and maintenance of remission in children with ulcerative colitis?. Acta Paediatrica2013;102(6):e273‐8. [PUBMED: 23445275] ">Strisciuglio 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cow’s milk protein elimination diet (14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Usual diet (15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5/13 vs. 4/15 (month 6)</p> <p>7/13 vs. 8/15 (month 12)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012839-bbs2-0018" title="WrightR , TrueloveSC . A controlled therapeutic trial of various diets in ulcerative colitis. British Medical Journal1965;2(5454):138‐41. [PUBMED: 14304053] ">Wright 1965</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Milk‐free, low‐roughage diet (26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Exclusion diet and liberal consumption of milk and milk products (24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16/26 vs. 18/23 (month 12)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>Abbreviations: ITT, Intention‐to‐treat; N/A, not applicable; pHBI, partial Harvey‐Bradshaw Index; PP, per‐protocol </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of interventions and outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/full#CD012839-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012839-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intervention diet versus control diet in active Crohn's disease</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Induction of remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 High‐fiber, low refined carbohydrates diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.20 [0.53, 97.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Low microparticle diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [0.22, 43.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.00 [1.27, 315.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Highly restricted, organic diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.39, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 Low calcium diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.67, 2.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Surrogate inflammatory biomarker ‐ CRP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Highly restricted, organic diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Surrogate inflammatory biomarker ‐ ESR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Highly restricted, organic diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Endoscopic improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Highly restricted, organic diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Health related quality of life ‐ IBDQ <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>23.75 [7.12, 40.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Highly restricted, organic diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [‐17.86, 25.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Need for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Low microparticle diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.14, 65.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Low fiber diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.35, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Disease progression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Highly restricted, organic diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.6 [0.08, 4.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Low fiber diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.61, 2.72]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Intervention diet versus control diet in active Crohn's disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012839-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Intervention diet versus control diet in inactive Crohn's disease</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low refined carbohydrate diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>567</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.87, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [0.28, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Low red, processed meat diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.85, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Exclusion diets (low disaccharides, grains, saturated fats, red and processed meats) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Surrogate inflammatory biomarker ‐ CRP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Surrogate inflammatory biomarker ‐ ESR <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.29 [‐17.22, 2.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.29 [‐17.22, 2.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Need for surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.19, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Low refined carbohydrate diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.19, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Disease progression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Low refined carbohydrate diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Escalation of therapy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Low refined carbohydrate diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Withdrawals due to adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Intervention diet versus control diet in inactive Crohn's disease</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012839-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Intervention diet versus control diet in active ulcerative colitis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Induction of remission <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.25 [0.50, 136.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Clinical improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Endoscopic improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Histologic improvement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Symptoms‐guided diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Intervention diet versus control diet in active ulcerative colitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012839-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Intervention diet versus control diet in inactive ulcerative colitis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Clinical relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Anti‐inflammatory diet (Alberta‐based)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.42, 3.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Carrageenan‐free diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.15, 1.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Milk free diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.60, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Fecal calprotectin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Carrageenan‐free diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Surrogate inflammatory biomarker ‐ TNF‐α <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Carrageenan‐free diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Surrogate inflammatory biomarker ‐ IL‐6 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Carrageenan‐free diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Surrogate inflammatory biomarker ‐ IL‐8 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Carrageenan‐free diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Health related quality of life ‐ SIBDQ <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Carrageenan‐free diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Intervention diet versus control diet in inactive ulcerative colitis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012839.pub2/references#CD012839-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012839.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012839-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012839-note-0006">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012839-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012839-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD012839-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012839-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012839-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012839\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012839\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012839\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012839\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012839\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012839.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012839.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012839.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012839.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012839.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726368389"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012839.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726368393"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012839.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e91f34f989368',t:'MTc0MDcyNjM2OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 